Workday (WDAY) 10-Q 29 Nov 22 2023 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares shares in Millions	9 Months Ended
	Oct. 31, 2022	Nov. 23, 2022
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2022
Document Transition Report	false
Entity File Number	001-35680
Entity Registrant Name	WORKDAY, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-2480422
Entity Address, Address Line One	6110 Stoneridge Mall Road
Entity Address, City or Town	Pleasanton
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94588
City Area Code	925
Local Phone Number	951-9000
Title of 12(b) Security	Class A Common Stock, par value $0.001
Trading Symbol	WDAY
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001327811
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false
Class A
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		202
Class B
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		55

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Current assets:
Cash and cash equivalents	$ 1,575,955	$ 1,534,273
Marketable securities	3,916,130	2,109,888
Trade and other receivables, net	1,040,468	1,242,545
Deferred costs	171,100	152,957
Prepaid expenses and other current assets	266,622	174,402
Total current assets	6,970,275	5,214,065
Property and equipment, net	1,219,127	1,123,075
Operating lease right-of-use assets	268,110	247,808
Deferred costs, noncurrent	359,624	341,259
Acquisition-related intangible assets, net	326,670	391,002
Goodwill	2,840,044	2,840,044
Other assets	405,937	341,252
Total assets	12,389,787	10,498,505
Current liabilities:
Accounts payable	75,803	55,487
Accrued expenses and other current liabilities	334,961	195,590
Accrued compensation	406,799	402,885
Unearned revenue	2,815,599	3,110,947
Operating lease liabilities	90,237	80,503
Debt, current	0	1,222,443
Total current liabilities	3,723,399	5,067,855
Debt, noncurrent	2,974,979	617,354
Unearned revenue, noncurrent	63,736	71,533
Operating lease liabilities, noncurrent	196,078	182,456
Other liabilities	22,487	24,225
Total liabilities	6,980,679	5,963,423
Stockholders’ equity:
Common stock	257	251
Additional paid-in capital	8,400,756	7,284,174
Treasury stock	(110,382)	(12,467)
Accumulated other comprehensive income (loss)	104,114	7,709
Accumulated deficit	(2,985,637)	(2,744,585)
Total stockholders’ equity	5,409,108	4,535,082
Total liabilities and stockholders’ equity	$ 12,389,787	$ 10,498,505

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Revenues:
Total revenues		$ 1,599,103	$ 1,327,263	$ 4,569,558	$ 3,762,657
Costs and expenses:
Product development	[1]	565,727	455,615	1,655,071	1,341,482
Sales and marketing	[1]	470,196	366,323	1,358,198	1,050,974
General and administrative	[1]	153,708	121,656	427,832	347,391
Total costs and expenses		1,625,424	1,303,318	4,702,800	3,778,145
Operating income (loss)		(26,321)	23,945	(133,242)	(15,488)
Other income (expense), net		4,163	21,557	(48,789)	115,491
Income (loss) before provision for (benefit from) income taxes		(22,158)	45,502	(182,031)	100,003
Provision for (benefit from) income taxes		52,563	2,090	59,021	(2,623)
Net income (loss)		$ (74,721)	$ 43,412	$ (241,052)	$ 102,626
Net income (loss) per share, basic (in dollars per share)		$ (0.29)	$ 0.17	$ (0.95)	$ 0.42
Net income (loss) per share, diluted (in dollars per share)		$ (0.29)	$ 0.17	$ (0.95)	$ 0.40
Weighted-average shares used to compute net income (loss) per share, basic (in shares)		255,753	248,468	253,975	246,348
Weighted-average shares used to compute net income (loss) per share, diluted (in shares)		255,753	254,760	253,975	253,917
Subscription services
Revenues:
Total revenues		$ 1,432,393	$ 1,171,517	$ 4,071,804	$ 3,317,140
Costs and expenses:
Total costs and expenses	[1]	259,397	200,700	737,301	575,646
Professional services
Revenues:
Total revenues		166,710	155,746	497,754	445,517
Costs and expenses:
Total costs and expenses	[1]	$ 176,396	$ 159,024	$ 524,398	$ 462,652
[1] (1) Costs and expenses include share-based compensation expenses as follows: Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Costs of subscription services $ 25,598 $ 21,340 $ 76,918 $ 62,478 Costs of professional services 26,577 29,105 79,999 83,331 Product development 149,279 135,591 449,764 395,345 Sales and marketing 61,186 55,645 180,233 158,121 General and administrative 51,556 39,437 146,795 111,197 Total share-based compensation expenses $ 314,196 $ 281,118 $ 933,709 $ 810,472

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Total share-based compensation expenses	$ 314,196	$ 281,118	$ 933,709	$ 810,472
Costs of subscription services
Total share-based compensation expenses	25,598	21,340	76,918	62,478
Costs of professional services
Total share-based compensation expenses	26,577	29,105	79,999	83,331
Product development
Total share-based compensation expenses	149,279	135,591	449,764	395,345
Sales and marketing
Total share-based compensation expenses	61,186	55,645	180,233	158,121
General and administrative
Total share-based compensation expenses	$ 51,556	$ 39,437	$ 146,795	$ 111,197

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (74,721)	$ 43,412	$ (241,052)	$ 102,626
Other comprehensive income (loss):
Net change in foreign currency translation adjustment	(3,098)	(361)	(6,005)	(1,362)
Net change in unrealized gains (losses) on available-for-sale debt securities	(13,232)	(1,505)	(23,513)	(2,611)
Net change in unrealized gains (losses) on cash flow hedges	57,483	25,389	125,923	38,316
Other comprehensive income (loss)	41,153	23,523	96,405	34,343
Comprehensive income (loss)	$ (33,568)	$ 66,935	$ (144,647)	$ 136,969

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common stock:	Additional paid-in capital:	Additional paid-in capital: Cumulative Effect, Period of Adoption, Adjustment	Treasury stock:	Accumulated other comprehensive income (loss):	Accumulated deficit:	Accumulated deficit: Cumulative Effect, Period of Adoption, Adjustment
Balance, beginning (in shares) at Jan. 31, 2021		242,667
Balance, beginning at Jan. 31, 2021		$ 242	$ 6,254,936	$ (219,702)	$ (12,384)	$ (54,970)	$ (2,909,990)	$ 136,032
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee equity plans, net of shares withheld for employee taxes (in shares)		6,767
Issuance of common stock under employee equity plans, net of shares withheld for employee taxes		$ 7	76,374
Settlement of convertible senior notes (in shares)		0
Settlement of convertible senior notes		$ 0	(2)
Share-based compensation			808,299
Exercise of convertible senior notes hedges			58		(53)
Other comprehensive income (loss)	$ 34,343					34,343
Net income (loss)	102,626						102,626
Purchase of treasury stock from the exercise of convertible senior notes hedges (in shares)		0
Other (in shares)		125
Balance, ending (in shares) at Oct. 31, 2021		249,559
Balance, ending at Oct. 31, 2021	4,215,816	$ 249	6,919,963		(12,437)	(20,627)	(2,671,332)
Balance, beginning (in shares) at Jul. 31, 2021		248,087
Balance, beginning at Jul. 31, 2021		$ 248	6,639,067	0	(12,431)	(44,150)	(2,714,744)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee equity plans, net of shares withheld for employee taxes (in shares)		1,429
Issuance of common stock under employee equity plans, net of shares withheld for employee taxes		$ 1	1,893
Settlement of convertible senior notes (in shares)		0
Settlement of convertible senior notes		$ 0	0
Share-based compensation			278,995
Exercise of convertible senior notes hedges			8		(6)
Other comprehensive income (loss)	23,523					23,523
Net income (loss)	43,412						43,412
Purchase of treasury stock from the exercise of convertible senior notes hedges (in shares)		0
Other (in shares)		43
Balance, ending (in shares) at Oct. 31, 2021		249,559
Balance, ending at Oct. 31, 2021	4,215,816	$ 249	6,919,963		(12,437)	(20,627)	(2,671,332)
Balance, beginning (in shares) at Jan. 31, 2022		251,209
Balance, beginning at Jan. 31, 2022	4,535,082	$ 251	7,284,174	0	(12,467)	7,709	(2,744,585)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee equity plans, net of shares withheld for employee taxes (in shares)		5,474
Issuance of common stock under employee equity plans, net of shares withheld for employee taxes		$ 5	84,997
Settlement of convertible senior notes (in shares)		635
Settlement of convertible senior notes		$ 1	(40)
Share-based compensation			933,709
Exercise of convertible senior notes hedges			97,916		(97,915)
Other comprehensive income (loss)	96,405					96,405
Net income (loss)	(241,052)						(241,052)
Purchase of treasury stock from the exercise of convertible senior notes hedges (in shares)		(635)
Other (in shares)		0
Balance, ending (in shares) at Oct. 31, 2022		256,683
Balance, ending at Oct. 31, 2022	5,409,108	$ 257	8,400,756		(110,382)	104,114	(2,985,637)
Balance, beginning (in shares) at Jul. 31, 2022		255,485
Balance, beginning at Jul. 31, 2022		$ 255	7,988,096	$ 0	(12,588)	62,961	(2,910,916)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee equity plans, net of shares withheld for employee taxes (in shares)		1,198
Issuance of common stock under employee equity plans, net of shares withheld for employee taxes		$ 1	709
Settlement of convertible senior notes (in shares)		634
Settlement of convertible senior notes		$ 1	(39)
Share-based compensation			314,196
Exercise of convertible senior notes hedges			97,794		(97,794)
Other comprehensive income (loss)	41,153					41,153
Net income (loss)	(74,721)						(74,721)
Purchase of treasury stock from the exercise of convertible senior notes hedges (in shares)		(634)
Other (in shares)		0
Balance, ending (in shares) at Oct. 31, 2022		256,683
Balance, ending at Oct. 31, 2022	$ 5,409,108	$ 257	$ 8,400,756		$ (110,382)	$ 104,114	$ (2,985,637)

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Cash flows from operating activities:
Net income (loss)	$ (74,721)	$ 43,412	$ (241,052)	$ 102,626
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	91,854	87,127	274,395	254,973
Share-based compensation expenses	314,196	278,995	933,709	808,349
Amortization of deferred costs	44,830	35,482	126,515	100,844
Non-cash lease expense	23,359	21,407	68,318	64,706
(Gains) losses on investments	(3,833)	(25,222)	20,746	(125,479)
Other	3,251	4,408	15,373	(4,225)
Changes in operating assets and liabilities, net of business combinations:
Trade and other receivables, net	61,885	6,649	200,008	171,257
Deferred costs	(56,552)	(50,654)	(163,023)	(129,758)
Prepaid expenses and other assets	2,435	18,050	(31,447)	(21,047)
Accounts payable	18,116	(12,007)	20,884	(4,117)
Accrued expenses and other liabilities	47,061	2,498	41,253	(24,109)
Unearned revenue	(63,213)	(25,491)	(302,936)	(158,465)
Net cash provided by (used in) operating activities	408,668	384,654	962,743	1,035,555
Cash flows from investing activities:
Purchases of marketable securities	(2,310,915)	(722,275)	(5,651,005)	(2,317,040)
Maturities of marketable securities	2,181,147	674,246	3,767,509	2,303,478
Sales of marketable securities	19,988	0	53,355	27,286
Owned real estate projects	(181)	(4)	(446)	(171,498)
Capital expenditures, excluding owned real estate projects	(58,665)	(33,335)	(286,013)	(190,912)
Business combinations, net of cash acquired	0	(60,645)	0	(739,865)
Purchase of other intangible assets	(700)	0	(700)	0
Purchases of non-marketable equity and other investments	(3,250)	(26,720)	(20,173)	(84,526)
Sales and maturities of non-marketable equity and other investments	4,513	1,874	11,674	5,169
Other	0	0	0	1
Net cash provided by (used in) investing activities	(168,063)	(166,859)	(2,125,799)	(1,167,907)
Cash flows from financing activities:
Proceeds from issuance of debt, net of debt discount	0	0	2,978,077	0
Repayments and extinguishment of debt	(1,149,622)	(9,384)	(1,843,605)	(28,205)
Payments for debt issuance costs	0	0	(7,220)	0
Proceeds from issuance of common stock from employee equity plans, net of taxes paid for shares withheld	710	1,894	85,002	76,381
Other	(161)	(33)	(538)	(409)
Net cash provided by (used in) financing activities	(1,149,073)	(7,523)	1,211,716	47,767
Effect of exchange rate changes	(920)	50	(1,750)	(85)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(909,388)	210,322	46,910	(84,670)
Cash, cash equivalents, and restricted cash at the beginning of period	2,497,043	1,092,929	1,540,745	1,387,921
Cash, cash equivalents, and restricted cash at the end of period	1,587,655	1,303,251	1,587,655	1,303,251
Supplemental cash flow data:
Cash paid for interest	56,567	3,837	59,508	10,904
Cash paid for income taxes, net of refunds	2,093	2,716	9,863	9,150
Non-cash investing and financing activities:
Purchases of property and equipment, accrued but not paid	68,028	49,713	68,028	49,713
Reconciliation of cash, cash equivalents, and restricted cash as shown in the Condensed Consolidated Statements of Cash Flows:
Cash and cash equivalents	1,575,955	1,297,259	1,575,955	1,297,259
Restricted cash	11,700	5,992	11,700	5,992
Total cash, cash equivalents, and restricted cash	$ 1,587,655	$ 1,303,251	$ 1,587,655	$ 1,303,251

Overview and Basis of Presentat

Overview and Basis of Presentation	9 Months Ended
	Oct. 31, 2022
Accounting Policies [Abstract]
Overview and Basis of Presentation	Overview and Basis of Presentation Company and Background Workday delivers applications for financial management, spend management, human capital management, planning, and analytics. With Workday, our customers have a unified system that can help them plan, execute, analyze, and extend to other applications and environments, thereby helping them continuously adapt how they manage their business and operations. We were originally incorporated in March 2005 in Nevada, and in June 2012, we reincorporated in Delaware. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The condensed consolidated financial statements include the results of Workday, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of our management, the information contained herein reflects all adjustments necessary for a fair presentation of Workday’s financial position, results of operations, stockholders’ equity, and cash flows. All such adjustments are of a normal, recurring nature. The results of operations for the three and nine months ended October 31, 2022, shown in this report are not necessarily indicative of the results to be expected for the full fiscal year ending January 31, 2023. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended January 31, 2022, filed with the SEC on February 28, 2022. Certain prior period amounts reported in our consolidated financial statements and notes thereto have been reclassified to conform to current period presentation. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires us to make certain estimates, judgements, and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period. For revenue recognition, examples of significant estimates, judgements, and assumptions include the identification of distinct performance obligations and the assessment of the standalone selling price for each performance obligation identified. Other significant estimates, judgements, and assumptions include, but are not limited to, the determination of the period of benefit for deferred commissions, the fair value and useful lives of assets acquired and liabilities assumed through business combinations, and the valuation of non-marketable equity investments. Actual results could differ from those estimates, judgements, and assumptions, and such differences could be material to our condensed consolidated financial statements. Segment Information We operate in one operating segment, cloud applications. Operating segments are defined as components of an enterprise where separate financial information is evaluated regularly by a chief operating decision maker (“CODM”) in deciding how to allocate resources and assessing performance. For the nine months ended October 31, 2022, both our Co-Chief Executive Officer and Chairman, Aneel Bhusri, and our Co-Chief Executive Officer, Chano Fernandez, together serve as our CODM. Our CODM allocates resources and assesses performance based upon discrete financial information at the consolidated level.

Significant Accounting Policies

Significant Accounting Policies and Accounting Standards	9 Months Ended
	Oct. 31, 2022
Accounting Policies [Abstract]
Significant Accounting Policies and Accounting Standards	Significant Accounting Policies and Accounting Standards Significant Accounting Policies There have been no material changes in our significant accounting policies as described in our Annual Report on Form 10-K for the fiscal year ended January 31, 2022. Concentrations of Risk and Significant Customers Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, debt securities, and trade and other receivables. Our deposits exceed federally insured limits. No customer individually accounted for more than 10% of trade and other receivables, net as of October 31, 2022, or January 31, 2022. No customer individually accounted for more than 10% of total revenues during the three and nine months ended October 31, 2022, or 2021. Other than the United States, no country individually accounted for more than 10% of total revenues during the three and nine months ended October 31, 2022, or 2021. In order to reduce the risk of down-time of our cloud applications, we have established data centers in various geographic regions. We serve our customers and users from data center facilities operated by third parties, located in the United States, Canada, and Europe. We have internal procedures to restore services in the event of disaster at one of our data center facilities. Even with these procedures for disaster recovery in place, our cloud applications could be significantly interrupted during the implementation of the procedures to restore services. In addition, we rely upon third-party hosted infrastructure partners globally, including Amazon Web Services (“AWS”), Google LLC, and Microsoft Corporation, to serve customers and operate certain aspects of our services. Given this, any disruption of or interference at our hosted infrastructure partners would impact our operations and our business could be adversely impacted. Recently Adopted Accounting Pronouncements ASU No. 2021-08 In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured in accordance with Topic 606, Revenue from Contracts with Customers, as if the acquirer had originated the contracts. Prior to the adoption of the new standard, such assets and liabilities were recognized by the acquirer at fair value on the acquisition date. We early adopted ASU No. 2021-08 on a prospective basis effective February 1, 2022. The adoption had no impact on our condensed consolidated financial statements during the three and nine months ended October 31, 2022, and any financial impact will be dependent on the magnitude and nature of future business combinations.

Investments

Investments	9 Months Ended
	Oct. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Investments	Investments Debt Securities As of October 31, 2022, debt securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value U.S. treasury securities $ 2,391,963 $ 1 $ (10,333) $ 2,381,631 U.S. agency obligations 548,109 — (6,020) 542,089 Corporate bonds 624,186 18 (11,877) 612,327 Commercial paper 1,054,938 — — 1,054,938 Total debt securities $ 4,619,196 $ 19 $ (28,230) $ 4,590,985 Included in Cash and cash equivalents $ 757,758 $ — $ (113) $ 757,645 Included in Marketable securities $ 3,861,438 $ 19 $ (28,117) $ 3,833,340 As of January 31, 2022, debt securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value U.S. treasury securities $ 843,627 $ 5 $ (1,720) $ 841,912 U.S. agency obligations 232,093 — (1,168) 230,925 Corporate bonds 490,867 — (1,815) 489,052 Commercial paper 969,204 — — 969,204 Total debt securities $ 2,535,791 $ 5 $ (4,703) $ 2,531,093 Included in Cash and cash equivalents $ 525,524 $ — $ (1) $ 525,523 Included in Marketable securities $ 2,010,267 $ 5 $ (4,702) $ 2,005,570 We classify our debt securities as available-for-sale at the time of purchase and reevaluate such classification as of each balance sheet date. We consider all debt securities as funds available for use in current operations, including those with maturity dates beyond one year, and therefore classify these securities as current assets on the Condensed Consolidated Balance Sheets. Debt securities included in Marketable securities on the Condensed Consolidated Balance Sheets consist of securities with original maturities at the time of purchase greater than three months, and the remaining securities are included in Cash and cash equivalents. As of October 31, 2022, and January 31, 2022, the fair value of debt securities in an unrealized loss position was $3.5 billion and $1.5 billion, respectively, the majority of which had been in a continuous unrealized loss position for less than 12 months. We did not recognize any credit or non-credit related losses related to our debt securities during the periods presented. We sold $20 million of debt securities during the three months ended October 31, 2022, and we did not have any sales of debt securities during the three months ended October 31, 2021. We sold $48 million and $10 million of debt securities during the nine months ended October 31, 2022, and 2021, respectively. The realized gains and losses from the sales were immaterial. Equity Investments Equity investments consisted of the following (in thousands): Condensed Consolidated Balance Sheets Location October 31, 2022 January 31, 2022 Money market funds Cash and cash equivalents $ 528,633 $ 607,640 Non-marketable equity investments measured using the measurement alternative Other assets 265,573 256,643 Marketable equity investments Marketable securities 82,790 104,318 Total equity investments $ 876,996 $ 968,601 Total realized and unrealized gains and losses associated with our equity investments consisted of the following (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Net realized gains (losses) recognized on equity investments sold (1) $ 4,514 $ 11,759 $ (365) $ 4,236 Net unrealized gains (losses) recognized on equity investments held as of the end of the period (155) 13,448 (19,121) 121,167 Total net gains (losses) recognized in Other income (expense), net $ 4,359 $ 25,207 $ (19,486) $ 125,403 (1) Reflects the difference between the sale proceeds and the carrying value of the equity investments at the beginning of the period. Non-Marketable Equity Investments Measured Using the Measurement Alternative Non-marketable equity investments measured using the measurement alternative include investments in privately held companies without readily determinable fair values in which we do not own a controlling interest or exercise significant influence. These investments are recorded at cost and are adjusted for observable transactions for same or similar securities of the same issuer or impairment events. The carrying values for our non-marketable equity investments are summarized below (in thousands): October 31, 2022 January 31, 2022 Total initial cost $ 209,867 $ 192,694 Cumulative net unrealized gains (losses) 55,706 63,949 Carrying value $ 265,573 $ 256,643 During the three months ended October 31, 2022, we recorded upward adjustments to the carrying value of non-marketable equity investments of $2 million, impairment losses of $2 million, and a gain of $4 million upon exiting a non-marketable equity investment. During the three months ended October 31, 2021, we recorded upward adjustments to the carrying value of non-marketable equity investments of $20 million and a non-cash gain of $12 million related to our acquisition of Zimit. During the nine months ended October 31, 2022, we recorded upward adjustments to the carrying value of non-marketable equity investments of $8 million, impairment losses of $10 million, and a net loss of $2 million upon exiting a non-marketable equity investment. During the nine months ended October 31, 2021, we recorded upward adjustments to the carrying value of non-marketable equity investments of $34 million, impairment losses of $2 million, and a non-cash gain of $12 million related to our acquisition of Zimit. Marketable Equity Investments We hold marketable equity investments with readily determinable fair values over which we do not own a controlling interest or exercise significant influence. The carrying values for our marketable equity investments are summarized below (in thousands): October 31, 2022 January 31, 2022 Total initial cost $ 38,936 $ 40,739 Cumulative net unrealized gains (losses) 43,854 63,579 Carrying value $ 82,790 $ 104,318 During the three months ended October 31, 2022, and 2021, we did not sell any marketable equity investments. During the nine months ended October 31, 2022, and 2021, we sold marketable equity investments for proceeds of $5 million and $17 million, respectively, with corresponding net realized gains of $1 million and losses of $6 million, respectively. For the marketable equity investments held as of the end of each period, we recorded no material unrealized net gains or losses during the three months ended October 31, 2022, and we recorded net losses of $7 million during the three months ended October 31, 2021. During the nine months ended October 31, 2022, and 2021, we recorded unrealized net losses of $17 million and gains of $91 million, respectively, on marketable equity investments held as of the end of each period.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements We use a fair value hierarchy that requires we maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value: Level 1 — Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 — Other inputs that are directly or indirectly observable in the marketplace. Level 3 — Unobservable inputs that are supported by little or no market activity. Assets and Liabilities Measured at Fair Value on a Recurring Basis The following table presents information about our assets and liabilities that are measured at fair value on a recurring basis and their assigned levels within the valuation hierarchy as of October 31, 2022 (in thousands): Level 1 Level 2 Level 3 Total U.S. treasury securities $ 2,381,631 $ — $ — $ 2,381,631 U.S. agency obligations — 542,089 — 542,089 Corporate bonds — 612,327 — 612,327 Commercial paper — 1,054,938 — 1,054,938 Money market funds 528,633 — — 528,633 Marketable equity investments 82,790 — — 82,790 Foreign currency derivative assets — 159,292 — 159,292 Total assets $ 2,993,054 $ 2,368,646 $ — $ 5,361,700 Foreign currency derivative liabilities $ — $ 36,486 $ — $ 36,486 Total liabilities $ — $ 36,486 $ — $ 36,486 The following table presents information about our assets and liabilities that are measured at fair value on a recurring basis and their assigned levels within the valuation hierarchy as of January 31, 2022 (in thousands): Level 1 Level 2 Level 3 Total U.S. treasury securities $ 841,912 $ — $ — $ 841,912 U.S. agency obligations — 230,925 — 230,925 Corporate bonds — 489,052 — 489,052 Commercial paper — 969,204 — 969,204 Money market funds 607,640 — — 607,640 Marketable equity investments 104,318 — — 104,318 Foreign currency derivative assets — 39,031 — 39,031 Total assets $ 1,553,870 $ 1,728,212 $ — $ 3,282,082 Foreign currency derivative liabilities $ — $ 13,039 $ — $ 13,039 Total liabilities $ — $ 13,039 $ — $ 13,039 Non-Marketable Equity Investments Measured at Fair Value on a Non-Recurring Basis Non-marketable equity investments that have been remeasured due to an observable event or impairment are classified within Level 3 in the fair value hierarchy because we estimate the value based on valuation methods which may include a combination of the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the investments we hold. For further information, see Note 3, Investments . Fair Value Measurements of Other Financial Instruments We carry our debt at face value less unamortized debt discount and issuance costs on our Condensed Consolidated Balance Sheets and present the fair value for disclosure purposes only. All of our debt obligations are categorized as Level 2 financial instruments. For further information on the fair values of our debt and the inputs used in the calculations, see Note 10, Debt .

Deferred Costs

Deferred Costs	9 Months Ended
	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Deferred Costs	Deferred Costs Deferred costs, which consist of deferred sales commission s, were $531 million and $494 million as of October 31, 2022, and January 31, 2022, respectively. Amortization expense for the deferred costs was $45 million and $36 million for the three months ended October 31, 2022, and 2021, respectively, and $127 million and $101 million for the nine months ended October 31, 2022, and 2021, respectively. There was no impairment loss in relation to the costs capitalized for the periods presented. Subscription services revenues o f $1.2 billion and $1.0 billion were recognized during the three months ended October 31, 2022, and 2021, respectively, that were included in the unearned revenue balances as of July 31, 2022 , and 2021 , respectively. Subscription services revenues of $2.7 billion and $2.2 billion were recognized during the nine months ended October 31, 2022, and 2021, respectively, that were included in the unearned revenue balances as of January 31, 2022, and 2021, respectively. Professional services revenues recognized in the same periods from unearned revenue balances at the beginning of the respective periods were not material. Transaction Price Allocated to the Remaining Performance Obligations As of October 31, 2022, approximately $14.1 billion of revenues are expected to be recognized from remaining performance obligations for subscription contracts. We expect to recognize revenues on approximately $8.6 billion of these remaining performance obligations over the next 24 months, with the balance recognized thereafter. Revenues from remaining performance obligations for professional services contracts as of October 31, 2022, were not material.

Property and Equipment, Net

Property and Equipment, Net	9 Months Ended
	Oct. 31, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): October 31, 2022 January 31, 2022 Computers, equipment, and software $ 1,292,126 $ 1,071,141 Buildings 718,495 691,896 Leasehold improvements 183,206 158,037 Furniture, fixtures, and transportation equipment 88,090 79,723 Land and land improvements 80,929 80,553 Property and equipment, gross 2,362,846 2,081,350 Less accumulated depreciation and amortization (1,143,719) (958,275) Property and equipment, net $ 1,219,127 $ 1,123,075 Depre ciation expense totaled $69 million and $66 million for the three months ended October 31, 2022, and 2021, respectively, and $207 million and $194 million for the nine months ended October 31, 2022, and 2021, respectively.

Acquisition-Related Intangible

Acquisition-Related Intangible Assets, Net	9 Months Ended
	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Acquisition-Related Intangible Assets, Net	Acquisition-Related Intangible Assets, Net Acquisition-related intangible assets, net consisted of the following (in thousands): October 31, 2022 January 31, 2022 Developed technology $ 346,300 $ 346,300 Customer relationships 311,100 311,100 Backlog 15,000 15,000 Trade name 12,500 12,500 Acquisition-related intangible assets, gross 684,900 684,900 Less accumulated amortization (358,230) (293,898) Acquisition-related intangible assets, net $ 326,670 $ 391,002 Amortization expense related to acquisition-related intangible assets was $21 million and $19 million for the three months ended October 31, 2022, and 2021, respectively, and $64 million and $57 million for the nine months ended October 31, 2022, and 2021, respectively. As of October 31, 2022, our future estimated amortization expense related to acquisition-related intangible assets was as follows (in thousands): Fiscal Period: Remainder of 2023 $ 21,204 2024 74,319 2025 61,663 2026 55,748 2027 31,177 Thereafter 82,559 Total $ 326,670

Other Assets

Other Assets	9 Months Ended
	Oct. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Assets	Other Assets Other noncurrent assets consisted of the following (in thousands): October 31, 2022 January 31, 2022 Non-marketable equity and other investments $ 268,543 $ 256,759 Derivative assets 71,482 16,618 Technology patents and other intangible assets, net 20,921 22,792 Prepayments for goods and services 18,767 25,927 Net deferred tax assets 9,441 11,642 Deposits 5,345 6,701 Other 11,438 813 Total other assets $ 405,937 $ 341,252 Technology patents and other intangible assets with estimable useful lives are amortized on a straight-line basis. As of October 31, 2022, the future estimated amortization expense was as follows (in thousands): Fiscal Period: Remainder of 2023 $ 853 2024 3,172 2025 2,689 2026 2,434 2027 2,150 Thereafter 9,623 Total $ 20,921

Derivative Instruments

Derivative Instruments	9 Months Ended
	Oct. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments We conduct business on a global basis in multiple foreign currencies, subjecting Workday to foreign currency exchange risk. To mitigate this risk, we utilize derivative hedging contracts as described below. We do not enter into any derivatives for trading or speculative purposes. Our foreign currency contracts are classified within Level 2 of the fair value hierarchy because the valuation inputs are based on quoted prices and market observable data of similar instruments in active markets, such as currency spot and forward rates. Cash Flow Hedges We enter into foreign currency forward contracts to hedge a portion of our forecasted revenue and expense transactions (“cash flow hedges”). We designate these forward contracts as cash flow hedging instruments since the accounting criteria for such designation has been met. Cash flow hedges are recorded on the Condensed Consolidated Balance Sheets at fair value. Cash flows from such forward contracts are classified as operating activities. Gains or losses resulting from changes in the fair value of these hedges are recorded in Accumulated other comprehensive income (loss) (“AOCI”) on the Condensed Consolidated Balance Sheets and are subsequently reclassified to the same line item as the hedged transaction on the Condensed Consolidated Statements of Operations in the same period that the hedged transaction affects earnings. As of October 31, 2022, we estimate that $39 million of net gains recorded in AOCI related to our cash flow hedges will be reclassified into income within the next 12 months. As of October 31, 2022, and January 31, 2022, the notional values of the cash flow hedges that we held to buy U.S. dollars in exchange for other currencies were $1.6 billion and $1.4 billion, respectively. The notional values of the cash flow hedges that we held to sell U.S. dollars in exchange for other currencies were $365 million and $355 million as of October 31, 2022, and January 31, 2022, respectively. All contracts had maturities of less than 48 months. Non-Designated Hedges We also enter into foreign currency forward contracts to hedge a portion of our net outstanding monetary assets and liabilities (“non-designated hedges”). These forward contracts are intended to offset foreign currency gains or losses associated with the underlying monetary assets and liabilities and are recorded on the Condensed Consolidated Balance Sheets at fair value. These forward contracts are not designated as hedging instruments under applicable accounting guidance, and therefore all changes in the fair value of these forward contracts are recorded in Other income (expense), net on the Condensed Consolidated Statements of Operations. Cash flows from such forward contracts are classified as operating activities. As of October 31, 2022, and January 31, 2022, the notional values of the non-designated hedges that we held to buy U.S. dollars in exchange for other currencies were $127 million and $217 million, respectively, and the notional values of the non-designated hedges that we held to sell U.S. dollars in exchange for other currencies were $34 million and $8 million, respectively. The fair values of outstanding derivative instruments were as follows (in thousands): Condensed Consolidated Balance Sheets Location October 31, 2022 January 31, 2022 Derivative assets: Cash flow hedges Prepaid expenses and other current assets $ 86,853 $ 21,337 Cash flow hedges Other assets 71,480 16,618 Non-designated hedges Prepaid expenses and other current assets 957 1,076 Non-designated hedges Other assets 2 — Total derivative assets $ 159,292 $ 39,031 Derivative liabilities: Cash flow hedges Accrued expenses and other current liabilities $ 31,331 $ 7,512 Cash flow hedges Other liabilities 1,500 5,175 Non-designated hedges Accrued expenses and other current liabilities 3,655 336 Non-designated hedges Other liabilities — 16 Total derivative liabilities $ 36,486 $ 13,039 The effect of cash flow hedges on the Condensed Consolidated Statements of Operations was as follows (in thousands): Three Months Ended October 31, 2022 2021 Revenues Costs and Expenses Income Tax Revenues Costs and Expenses Income Tax Total $ 1,599,103 $ 1,625,424 $ 52,563 $ 1,327,263 $ 1,303,318 $ 2,090 Gains (losses) related to cash flow hedges 5,647 (11,852) (3,220) (3,847) — — Nine Months Ended October 31, 2022 2021 Revenues Costs and Expenses Income Tax Revenues Costs and Expenses Income Tax Total $ 4,569,558 $ 4,702,800 $ 59,021 $ 3,762,657 $ 3,778,145 $ (2,623) Gains (losses) related to cash flow hedges 5,985 (18,636) (3,220) (4,996) — — Gains (losses) associated with cash flow hedges were as follows (in thousands): Consolidated Statements of Operations and Statements of Comprehensive Income (Loss) Locations Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Gains (losses) recognized in OCI Net change in unrealized gains (losses) on cash flow hedges $ 48,058 $ 21,542 $ 110,052 $ 33,320 Gains (losses) reclassified from AOCI into income (effective portion) Revenues 5,647 (3,847) 5,985 (4,996) Gains (losses) reclassified from AOCI into income (effective portion) Costs and expenses (11,852) — (18,636) — Gains (losses) reclassified from AOCI into income (effective portion) Income Tax (3,220) — (3,220) — Gains (losses) associated with non-designated hedges were as follows (in thousands): Condensed Consolidated Statements of Operations Location Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Gains (losses) related to non-designated hedges Other income (expense), net $ 7,187 $ 605 $ 13,288 $ 2,424 We are subject to netting agreements with all of the counterparties of the foreign exchange contracts, under which we are permitted to net settle transactions of the same currency with a single net amount payable by one party to the other. It is our policy to present the derivatives gross on the Condensed Consolidated Balance Sheets. Our foreign currency forward contracts are not subject to any credit contingent features or collateral requirements. We manage our exposure to counterparty risk by entering into contracts with a diversified group of major financial institutions and by actively monitoring outstanding positions. As of October 31, 2022, information related to these offsetting arrangements was as follows (in thousands): Gross Amounts of Recognized Assets Gross Amounts Offset on the Condensed Consolidated Balance Sheets Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets Net Assets Exposed Financial Instruments Cash Collateral Received Derivative assets: Counterparty A $ 30,677 $ — $ 30,677 $ (879) $ — $ 29,798 Counterparty B 33,589 — 33,589 (19,020) — 14,569 Counterparty C 14,153 — 14,153 (7,956) — 6,197 Counterparty D 72,310 — 72,310 (8,143) — 64,167 Counterparty E 8,563 — 8,563 (488) — 8,075 Total $ 159,292 $ — $ 159,292 $ (36,486) $ — $ 122,806 Gross Amounts of Recognized Liabilities Gross Amounts Offset on the Condensed Consolidated Balance Sheets Net Amounts of Liabilities Presented on the Condensed Consolidated Balance Sheets Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets Net Liabilities Exposed Financial Instruments Cash Collateral Pledged Derivative liabilities: Counterparty A $ 879 $ — $ 879 $ (879) $ — $ — Counterparty B 19,020 — 19,020 (19,020) — — Counterparty C 7,956 — 7,956 (7,956) — — Counterparty D 8,143 — 8,143 (8,143) — — Counterparty E 488 — 488 (488) — — Total $ 36,486 $ — $ 36,486 $ (36,486) $ — $ —

Debt

Debt	9 Months Ended
	Oct. 31, 2022
Debt Disclosure [Abstract]
Debt	Debt Outstanding debt consisted of the following (in thousands): October 31, 2022 January 31, 2022 2027 Notes $ 1,000,000 $ — 2029 Notes 750,000 — 2032 Notes 1,250,000 — 2022 Notes — 1,149,817 Term loan under the 2020 Credit Agreement — 693,750 Total principal amount 3,000,000 1,843,567 Less: unamortized debt discount and issuance costs (25,021) (3,770) Net carrying amount 2,974,979 1,839,797 Less: debt, current — (1,222,443) Debt, noncurrent $ 2,974,979 $ 617,354 As of October 31, 2022, the future principal payments for the outstanding debt were as follows (in thousands): Fiscal Period: Remainder of 2023 $ — 2024 — 2025 — 2026 — 2027 — Thereafter 3,000,000 Total principal amount $ 3,000,000 Senior Notes In April 2022, we issued $3.0 billion aggregate principal amount of senior notes, consisting of $1.0 billion aggregate principal amount of 3.500% notes due April 1, 2027 (“2027 Notes”), $750 million aggregate principal amount of 3.700% notes due April 1, 2029 (“2029 Notes”), and $1.25 billion aggregate principal amount of 3.800% notes due April 1, 2032 (“2032 Notes,” and together with the 2027 Notes and the 2029 Notes, “Senior Notes”). Interest is payable semi-annually in arrears on April 1 and October 1 of each year, commencing on October 1, 2022. The Senior Notes are unsecured obligations and rank equally with all existing and future unsecured and unsubordinated indebtedness of Workday. We may redeem the Senior Notes in whole or in part at any time or from time to time, at specified redemption dates and prices. In addition, upon the occurrence of certain change of control triggering events, we may be required to repurchase the Senior Notes under specified terms. The indenture governing the Senior Notes also includes covenants (including certain limited covenants restricting our ability to incur certain liens and enter into certain sale and leaseback transactions), events of default, and other customary provisions. As of October 31, 2022, we were in compliance with all covenants associated with the Senior Notes. We incurred debt discount and issuance costs of approximately $27 million in connection with the Senior Notes offering, which were allocated on a pro rata basis to the 2027 Notes, 2029 Notes, and 2032 Notes. The debt discount and issuance costs are amortized on a straight-line basis, which approximates the effective interest rate method, to interest expense over the contractual term of each arrangement. The effective interest rates on the 2027 Notes, 2029 Notes, and 2032 Notes, which are calculated as the contractual interest rates adjusted for the debt discount and issuance costs, are 3.67%, 3.82%, and 3.90%, respectively. As of October 31, 2022, the total estimated fair value of the Senior Notes was $2.7 billion. The estimated fair values of the Senior Notes, which we have classified as Level 2 financial instruments, were determined based on quoted bid prices in an over-the-counter market on the last trading day of the reporting period. Credit Agreement In April 2022, we entered into a credit agreement (“2022 Credit Agreement”) which provides for a revolving credit facility in an aggregate principal amount of $1.0 billion. The 2022 Credit Agreement replaced our prior credit agreement entered into in April 2020 (“2020 Credit Agreement”) which provided for a term loan facility in an aggregate original principal amount of $750 million and a revolving credit facility in an aggregate principal amount of $750 million. Concurrently with entering into the 2022 Credit Agreement, we paid off the remaining principal balance of $694 million on the term loan under the 2020 Credit Agreement and terminated the revolving credit facility under the 2020 Credit Agreement which had no outstanding balance. The modification to our revolving credit facility and extinguishment of the term loan under the 2020 Credit Agreement did not have a material impact to our Condensed Consolidated Statements of Operations for the nine months ended October 31, 2022. As of October 31, 2022, we had no outstanding revolving loans under the 2022 Credit Agreement. The revolving loans under the 2022 Credit Agreement may be borrowed, repaid, and reborrowed until April 6, 2027, at which time all amounts borrowed must be repaid. The revolving loans under the 2022 Credit Agreement will bear interest, at our option, at a base rate plus a margin of 0.000% to 0.500% or a secured overnight financing rate (“SOFR”) rate plus 10 basis points, plus a margin of 0.750% to 1.500%, with such margin being determined based on our consolidated leverage ratio or debt rating. We are also obligated to pay an ongoing commitment fee on undrawn amounts. The 2022 Credit Agreement contains customary representations, warranties, and affirmative and negative covenants, including a financial covenant, events of default, and indemnification provisions in favor of the lenders. The negative covenants include restrictions on the incurrence of liens and indebtedness, certain merger transactions, and other matters, all subject to certain exceptions. The financial covenant, based on a quarterly financial test, requires that we do not exceed a maximum leverage ratio of 3.50:1.00, subject to a step-up to 4.50:1.00 at our election for a certain period following an acquisition. As of October 31, 2022, we were in compliance with all covenants. Convertible Senior Notes In September 2017, we issued 0.25% convertible senior notes due October 1, 2022, with a principal amount of $1.15 billion (“2022 Notes”). The 2022 Notes were unsecured, unsubordinated obligations, and interest was payable in cash in arrears at a fixed rate of 0.25% on April 1 and October 1 of each year. During the three months ended October 31, 2022, the 2022 Notes were converted by note holders, and we repaid the $1.15 billion principal balance in cash. We also distributed approximately 0.6 million shares of our Class A common stock to note holders during the three months ended October 31, 2022, which represents the conversion value in excess of the principal amount. Notes Hedges In connection with the issuance of the 2022 Notes, we entered into convertible note hedge transactions (“Purchased Options”) which gave us the option to purchase, subject to anti-dilution adjustments substantially identical to those in the 2022 Notes, approximately 7.8 million shares of our Class A common stock for $147.10 per share. During the three months ended October 31, 2022, we received approximately 0.6 million shares of our Class A common stock from the exercise of the Purchased Options, which offset economic dilution to our Class A common stock upon conversion of the 2022 Notes. These shares are held as treasury stock as of October 31, 2022. The Purchased Options were separate transactions and were not part of the terms of the 2022 Notes, and expired on October 1, 2022. Warrants In connection with the issuance of the 2022 Notes, we also entered into warrant transactions to sell warrants (“Warrants”) to acquire, subject to anti-dilution adjustments, up to approximately 7.8 million shares over 60 scheduled trading days beginning in January 2023 of our Class A common stock at an exercise price of $213.96 per share. If the Warrants are not exercised on their exercise dates, they will expire. The Warrants will be net share settled, and the resulting number of shares of our common stock we will issue depends on the daily volume-weighted average stock prices over the 60 scheduled trading day period beginning on the first expiration date of the Warrants. If the market value per share of our Class A common stock exceeds the applicable exercise price of the Warrants, the Warrants will have a dilutive effect on our earnings per share, assuming that we are profitable. The Warrants are separate transactions and are not part of the terms of the 2022 Notes or the Purchased Options. The proceeds from the sale of the Warrants were recorded in Additional paid-in capital on the Condensed Consolidated Balance Sheets. Interest Expense on Debt The following table sets forth total interest expense recognized related to our debt (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Contractual interest expense $ 28,036 $ 3,140 $ 67,702 $ 9,462 Interest cost related to amortization and write-off of debt discount and issuance costs 1,557 997 6,000 2,991 Total interest expense $ 29,593 $ 4,137 $ 73,702 $ 12,453

Leases

Leases	9 Months Ended
	Oct. 31, 2022
Leases [Abstract]
Leases	Leases We have entered into operating lease agreements for our office space, data centers, and other property and equipment. Operating lease right-of-use assets w ere $268 million and $248 million as of October 31, 2022, and January 31, 2022, respectively, and operating lease liabilities were $286 million an d $263 million as of October 31, 2022, and January 31, 2022, respectively. We have also entered into finance lease agreements for other property and equipment. As of October 31, 2022, and January 31, 2022, finance leases were not material. The components of operating lease expense were as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Operating lease cost $ 25,404 $ 22,988 $ 73,821 $ 70,004 Short-term lease cost 854 1,204 3,001 5,419 Variable lease cost 12,787 8,756 32,970 18,519 Total operating lease cost $ 39,045 $ 32,948 $ 109,792 $ 93,942 Supplemental cash flow information related to our operating leases was as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Cash paid for operating lease liabilities $ 23,190 $ 21,802 $ 68,386 $ 68,375 Operating lease right-of-use assets obtained in exchange for new operating lease liabilities 6,611 15,646 93,091 54,335 Other information related to our operating leases was as follows: October 31, 2022 January 31, 2022 Weighted average remaining lease term (in years) 5 5 Weighted average discount rate 2.74 % 2.35 % As of October 31, 2022, maturities of operating lease liabilities were as follows (in thousands): Fiscal Period: Remainder of 2023 $ 26,000 2024 93,305 2025 76,088 2026 47,332 2027 26,790 Thereafter 45,548 Total lease payments 315,063 Less imputed interest (28,748) Total operating lease liabilities $ 286,315 As of October 31, 2022 , we have additional operating leases for data centers that had not yet commenced with total undiscounted lease payments of $52 million. These operating leases will commence in fiscal 2023 and fiscal 2024, with lease terms ranging from five

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Purchase Obligations Our purchase obligations are primarily related to agreements for third-party hosted infrastructure platforms, data center equipment and software, business technology software and support, and sales and marketing activities. During the nine months ended October 31, 2022, there were no material changes outside the ordinary course of business to our non-cancelable purchase obligations disclosed in our Annual Report on Form 10-K for the fiscal year ended January 31, 2022. Legal Matters We are a party to various legal proceedings and claims that arise in the ordinary course of business. We make a provision for a liability relating to legal matters when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed at least quarterly and adjusted to reflect the impacts of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular matter. In our opinion, as of October 31, 2022, there was not at least a reasonable possibility that we had incurred a material loss, or a material loss in excess of a recorded accrual, with respect to such loss contingencies.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Oct. 31, 2022
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Common Stock As of October 31, 2022, there were 202 million shares of Class A common stock, net of treasury stock, and 55 million shares of Class B common stock outstanding. The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote per share and each share of Class B common stock is entitled to 10 votes per share. Each share of Class B common stock can be converted into a share of Class A common stock at any time at the option of the holder. Employee Equity Plans On June 22, 2022, our stockholders approved the 2022 Equity Incentive Plan (“2022 Plan”), with a reserve of 30 million shares for issuance. The 2022 Plan serves as the successor to our 2012 Equity Incentive Plan (“2012 Plan” and, together with the 2022 Plan, “Stock Plans”). Awards that are granted on or after the effective date of the 2022 Plan will be granted pursuant to and subject to the terms and provisions of the 2022 Plan. Prior awards granted under the 2012 Plan continue to be subject to the terms and provisions of the 2012 Plan. As of October 31, 2022, we had 29 million shares of Class A common stock available for future grants. On June 22, 2022, our stockholders approved the Amended and Restated 2012 Employee Stock Purchase Plan (“ESPP”). Under the ESPP, eligible employees are granted options to purchase shares at the lower of 85% of the fair market value of the stock at the time of grant or 85% of the fair market value at the time of exercise. Options to purchase shares are granted twice yearly on or about June 1 and December 1, and are exercisable on or about the succeeding November 30 and May 31, respectively. Pursuant to the terms of the ESPP, the share reserve increased by 2 million shares on March 31, 2022. As of October 31, 2022, 5 million shares of Class A common stock were available for issuance under the ESPP. Restricted Stock Units The Stock Plans provide for the issuance of restricted stock units (“RSUs”) to employees and non-employees. RSUs generally vest over four years. A summary of information related to RSU activity during the nine months ended October 31, 2022, is as follows (in thousands, except per share data): Number of Shares Weighted-Average Grant Date Fair Value Balance as of January 31, 2022 11,808 $ 209.12 RSUs granted 8,198 205.45 RSUs vested (4,298) 202.82 RSUs forfeited (1,071) 205.52 Balance as of October 31, 2022 14,637 209.18 As of October 31, 2022, there was a total of $2.3 billion in unrecognized compensation cost, adjusted for estimated forfeitures, related to unvested RSUs, which is expected to be recognized over a weighted-average period of approximately three years. Performance-Based Restricted Stock Units During fiscal 2022, 0.4 million shares of performance-based restricted stock units (“PRSUs”) were granted to employees below the level of vice president that included both service conditions and performance conditions related to company-wide goals. These performance conditions were met and the PRSUs vested on March 15, 2022. During the nine months ended October 31, 2022, we recognized $16 million in compensation cost related to these PRSUs. We did not grant any company-wide PRSUs in fiscal 2023. Stock Options The Stock Plans provide for the issuance of incentive and nonstatutory stock options to employees and non-employees. Stock options issued under the Stock Plans generally are exercisable for periods not to exceed ten years and generally vest over five years. A summary of information related to stock option activity during the nine months ended October 31, 2022, is as follows (in millions, except number of shares which are reflected in thousands and per share data): Outstanding Stock Options Weighted-Average Exercise Price Aggregate Intrinsic Value Balance as of January 31, 2022 387 $ 20.09 $ 90 Stock options exercised (212) 13.46 Stock options canceled (45) 16.20 Balance as of October 31, 2022 130 32.20 16 Vested and expected to vest as of October 31, 2022 130 32.20 16 Exercisable as of October 31, 2022 130 32.16 16 As of October 31, 2022, unrecognized compensation cost related to unvested stock options was not material.

Unearned Revenue and Performanc

Unearned Revenue and Performance Obligations	9 Months Ended
	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Unearned Revenue and Performance Obligations	Deferred Costs Deferred costs, which consist of deferred sales commission s, were $531 million and $494 million as of October 31, 2022, and January 31, 2022, respectively. Amortization expense for the deferred costs was $45 million and $36 million for the three months ended October 31, 2022, and 2021, respectively, and $127 million and $101 million for the nine months ended October 31, 2022, and 2021, respectively. There was no impairment loss in relation to the costs capitalized for the periods presented. Subscription services revenues o f $1.2 billion and $1.0 billion were recognized during the three months ended October 31, 2022, and 2021, respectively, that were included in the unearned revenue balances as of July 31, 2022 , and 2021 , respectively. Subscription services revenues of $2.7 billion and $2.2 billion were recognized during the nine months ended October 31, 2022, and 2021, respectively, that were included in the unearned revenue balances as of January 31, 2022, and 2021, respectively. Professional services revenues recognized in the same periods from unearned revenue balances at the beginning of the respective periods were not material. Transaction Price Allocated to the Remaining Performance Obligations As of October 31, 2022, approximately $14.1 billion of revenues are expected to be recognized from remaining performance obligations for subscription contracts. We expect to recognize revenues on approximately $8.6 billion of these remaining performance obligations over the next 24 months, with the balance recognized thereafter. Revenues from remaining performance obligations for professional services contracts as of October 31, 2022, were not material.

Other Income (Expense), Net

Other Income (Expense), Net	9 Months Ended
	Oct. 31, 2022
Other Income and Expenses [Abstract]
Other Income (Expense), Net	Other Income (Expense), Net Other income (expense), net consisted of the following (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Interest income $ 31,252 $ 1,195 $ 50,473 $ 4,531 Interest expense (1) (29,626) (4,160) (73,804) (12,527) Other (2) 2,537 24,522 (25,458) 123,487 Total other income (expense), net $ 4,163 $ 21,557 $ (48,789) $ 115,491 (1) Interest expense primarily includes the contractual interest expense of our debt obligations, and the related non-cash interest expense attributable to amortization of the debt discount and issuance costs. For further information, see Note 10, Debt . (2) Other primarily includes the net gains (losses) from our equity investments. For further information, see Note 3, Investments .

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes We reported an income tax provision of $59 million and an income tax benefit of $3 million for the nine months ended October 31, 2022, and 2021, respectively. The income tax provision for the nine months ended October 31, 2022, was primarily attributable to a taxable gain recognized from integrating intellectual property, income tax expenses in profitable foreign jurisdictions, and an increase in state taxes due to capitalized research and development expenditures. The income tax benefit for the nine months ended October 31, 2021, was primarily attributable to excess tax benefit from stock option deductions in foreign jurisdictions, reversal of previously accrued tax liabilities upon favorable tax audit results, and amortization of intangibles from business combinations. The 2017 Tax Cuts and Jobs Act requires research and development expenditures incurred for the tax year beginning after December 31, 2021, to be capitalized and amortized ratably over five years for domestic research and fifteen years for international research. The mandatory capitalization requirement has no material impact to our fiscal 2023 income tax provision due to our tax attributes carryover and full valuation allowance position. On August 16, 2022, the U.S. enacted the Inflation Reduction Act (“IRA”) of 2022, which, among other things, implemented a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases, and several tax incentives to promote clean energy. We evaluated the provisions of the IRA and do not expect any material impact to our fiscal 2023 income tax provision. We are subject to income tax audits in the U.S. and foreign jurisdictions. We record liabilities related to uncertain tax positions and believe that we have provided adequate reserves for income tax uncertainties in all open tax years. Due to our history of tax losses, all years remain open to tax audit. We periodically evaluate the realizability of our net deferred tax assets based on all available evidence, both positive and negative. The realization of net deferred tax assets is dependent on our ability to generate sufficient future taxable income during periods prior to the expiration of tax attributes to fully utilize these assets. As of October 31, 2022, we continue to maintain a full valuation allowance on our deferred tax assets in certain jurisdictions.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	9 Months Ended
	Oct. 31, 2022
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	Net Income (Loss) Per Share Basic net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during the period, net of treasury stock. Diluted net income (loss) per share is computed by giving effect to all potentially dilutive shares of common stock, including our convertible senior notes, outstanding warrants related to the issuance of the convertible senior notes, and outstanding share-based awards consisting primarily of unvested RSUs and ESPP obligations. The net income (loss) per share is allocated based on the contractual participation rights of the Class A common shares and Class B common shares as if the income (loss) for the period had been distributed. As the liquidation and dividend rights are identical, the net income (loss) is allocated on a proportionate basis. The computation of the diluted net income (loss) per share of Class A common stock assumes the conversion of our Class B common stock to Class A common stock, while the diluted net income (loss) per share of Class B common stock does not assume the conversion of those shares. Basic and diluted net loss per share was the same for the three and nine months ended October 31, 2022, as the inclusion of all potential common shares outstanding would have been anti-dilutive. The following table presents the calculation of basic and diluted net income (loss) per share (in thousands, except per share data): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Class A Class B Class A Class B Class A Class B Class A Class B Net income (loss) per share, basic: Numerator: Net income (loss) $ (58,648) $ (16,073) $ 33,417 $ 9,995 $ (188,757) $ (52,295) $ 78,546 $ 24,080 Denominator: Weighted-average shares outstanding, basic 200,740 55,013 191,259 57,209 198,876 55,099 188,546 57,802 Net income (loss) per share, basic $ (0.29) $ (0.29) $ 0.17 $ 0.17 $ (0.95) $ (0.95) $ 0.42 $ 0.42 Net income (loss) per share, diluted: Numerator: Net income (loss) $ (58,648) $ (16,073) $ 33,417 $ 9,995 $ (188,757) $ (52,295) $ 78,546 $ 24,080 Reallocation of net income as a result of conversion of Class B to Class A common stock — — 9,995 — — — 24,080 — Reallocation of net income to Class B common stock — — — (247) — — — (718) Net income (loss) for diluted calculation (58,648) (16,073) 43,412 9,748 (188,757) (52,295) 102,626 23,362 Denominator: Weighted-average shares outstanding, basic 200,740 55,013 191,259 57,209 198,876 55,099 188,546 57,802 Conversion of Class B to Class A common stock — — 57,209 — — — 57,802 — Dilutive effect of share-based awards — — 4,933 — — — 6,456 — Dilutive effect of warrants related to the issuance of convertible senior notes — — 1,359 — — — 1,113 — Weighted-average shares outstanding, diluted 200,740 55,013 254,760 57,209 198,876 55,099 253,917 57,802 Net income (loss) per share, diluted $ (0.29) $ (0.29) $ 0.17 $ 0.17 $ (0.95) $ (0.95) $ 0.40 $ 0.40 The computation of diluted net income (loss) per share does not include the effect of the following potential weighted-average shares of common stock. The effects of these potentially outstanding shares were not included in the calculation of diluted net income (loss) per share because the effect would have been anti-dilutive (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Shares related to outstanding share-based awards 16,105 151 15,453 1,801 Shares related to the convertible senior notes 5,182 7,817 6,928 7,817 Shares subject to warrants related to the issuance of convertible senior notes 7,818 — 7,818 — Total 29,105 7,968 30,199 9,618

Geographic Information

Geographic Information	9 Months Ended
	Oct. 31, 2022
Segment Reporting [Abstract]
Geographic Information	Geographic Information Revenues We sell our subscription contracts and related services in two primary geographical markets: to customers located in the United States and to customers located outside of the United States. Revenues by geography are generally based on the address of the customer as specified in our customer subscription agreement. The following table sets forth revenues by geographic area (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 United States $ 1,204,842 $ 991,747 $ 3,432,249 $ 2,817,749 Other countries 394,261 335,516 1,137,309 944,908 Total revenues $ 1,599,103 $ 1,327,263 $ 4,569,558 $ 3,762,657 Long-Lived Assets Our long-lived assets, which primarily consist of property and equipment and operating lease right-of-use assets, are attributed to a country based on the physical location of the assets. Aggregate Property and equipment, net and Operating lease right-of-use assets by geographic area was as follows (in thousands): October 31, 2022 January 31, 2022 United States $ 1,243,176 $ 1,174,371 Ireland 158,975 117,049 Other countries 85,086 79,463 Total long-lived assets $ 1,487,237 $ 1,370,883

Subsequent Events

Subsequent Events	9 Months Ended
	Oct. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Share Repurchase Program In November 2022, our Board of Directors authorized the repurchase of up to $500 million of our outstanding shares of Class A common stock (the “Share Repurchase Program”). We may repurchase shares of Class A common stock from time to time through open market purchases, in privately negotiated transactions or by other means, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, in accordance with applicable securities laws and other restrictions. The timing and total amount of stock repurchases will depend upon business, economic and market conditions, corporate and regulatory requirements, prevailing stock prices, and other considerations. The Share Repurchase Program will have a term of 18 months, may be suspended or discontinued at any time, and does not obligate us to acquire any amount of Class A common stock. RSU Vesting Date Modification In November 2022, we modified the vesting date of all unvested RSU awards from the 15th to the 5th of each month. The change will impact awards vesting after December 31, 2022, and will result in an acceleration of share-based compensation expense of approximately $30 million in the fourth quarter of fiscal 2023.

Overview and Basis of Present_2

Overview and Basis of Presentation (Policies)	9 Months Ended
	Oct. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The condensed consolidated financial statements include the results of Workday, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of our management, the information contained herein reflects all adjustments necessary for a fair presentation of Workday’s financial position, results of operations, stockholders’ equity, and cash flows. All such adjustments are of a normal, recurring nature. The results of operations for the three and nine months ended October 31, 2022, shown in this report are not necessarily indicative of the results to be expected for the full fiscal year ending January 31, 2023. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended January 31, 2022, filed with the SEC on February 28, 2022.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires us to make certain estimates, judgements, and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period. For revenue recognition, examples of significant estimates, judgements, and assumptions include the identification of distinct performance obligations and the assessment of the standalone selling price for each performance obligation identified. Other significant estimates, judgements, and assumptions include, but are not limited to, the determination of the period of benefit for deferred commissions, the fair value and useful lives of assets acquired and liabilities assumed through business combinations, and the valuation of non-marketable equity investments. Actual results could differ from those estimates, judgements, and assumptions, and such differences could be material to our condensed consolidated financial statements.
Segment Information	Segment Information We operate in one operating segment, cloud applications. Operating segments are defined as components of an enterprise where separate financial information is evaluated regularly by a chief operating decision maker (“CODM”) in deciding how to allocate resources and assessing performance. For the nine months ended October 31, 2022, both our Co-Chief Executive Officer and Chairman, Aneel Bhusri, and our Co-Chief Executive Officer, Chano Fernandez, together serve as our CODM. Our CODM allocates resources and assesses performance based upon discrete financial information at the consolidated level.
Concentrations of Risk and Significant Customers	Concentrations of Risk and Significant Customers Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, debt securities, and trade and other receivables. Our deposits exceed federally insured limits. In order to reduce the risk of down-time of our cloud applications, we have established data centers in various geographic regions. We serve our customers and users from data center facilities operated by third parties, located in the United States, Canada, and Europe. We have internal procedures to restore services in the event of disaster at one of our data center facilities. Even with these procedures for disaster recovery in place, our cloud applications could be significantly interrupted during the implementation of the procedures to restore services. In addition, we rely upon third-party hosted infrastructure partners globally, including Amazon Web Services (“AWS”), Google LLC, and Microsoft Corporation, to serve customers and operate certain aspects of our services. Given this, any disruption of or interference at our hosted infrastructure partners would impact our operations and our business could be adversely impacted.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements ASU No. 2021-08 In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured in accordance with Topic 606, Revenue from Contracts with Customers, as if the acquirer had originated the contracts. Prior to the adoption of the new standard, such assets and liabilities were recognized by the acquirer at fair value on the acquisition date. We early adopted ASU No. 2021-08 on a prospective basis effective February 1, 2022. The adoption had no impact on our condensed consolidated financial statements during the three and nine months ended October 31, 2022, and any financial impact will be dependent on the magnitude and nature of future business combinations.
Investments	We classify our debt securities as available-for-sale at the time of purchase and reevaluate such classification as of each balance sheet date. We consider all debt securities as funds available for use in current operations, including those with maturity dates beyond one year, and therefore classify these securities as current assets on the Condensed Consolidated Balance Sheets. Debt securities included in Marketable securities on the Condensed Consolidated Balance Sheets consist of securities with original maturities at the time of purchase greater than three months, and the remaining securities are included in Cash and cash equivalents.
Fair Value Measurements	We use a fair value hierarchy that requires we maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value: Level 1 — Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 — Other inputs that are directly or indirectly observable in the marketplace. Level 3 — Unobservable inputs that are supported by little or no market activity.
Derivative Instruments	We conduct business on a global basis in multiple foreign currencies, subjecting Workday to foreign currency exchange risk. To mitigate this risk, we utilize derivative hedging contracts as described below. We do not enter into any derivatives for trading or speculative purposes. Our foreign currency contracts are classified within Level 2 of the fair value hierarchy because the valuation inputs are based on quoted prices and market observable data of similar instruments in active markets, such as currency spot and forward rates. Cash Flow Hedges We enter into foreign currency forward contracts to hedge a portion of our forecasted revenue and expense transactions (“cash flow hedges”). We designate these forward contracts as cash flow hedging instruments since the accounting criteria for such designation has been met.
Net Income (Loss) Per Share	Basic net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during the period, net of treasury stock. Diluted net income (loss) per share is computed by giving effect to all potentially dilutive shares of common stock, including our convertible senior notes, outstanding warrants related to the issuance of the convertible senior notes, and outstanding share-based awards consisting primarily of unvested RSUs and ESPP obligations. The net income (loss) per share is allocated based on the contractual participation rights of the Class A common shares and Class B common shares as if the income (loss) for the period had been distributed. As the liquidation and dividend rights are identical, the net income (loss) is allocated on a proportionate basis. The computation of the diluted net income (loss) per share of Class A common stock assumes the conversion of our Class B common stock to Class A common stock, while the diluted net income (loss) per share of Class B common stock does not assume the conversion of those shares.

Investments (Tables)

Investments (Tables)	9 Months Ended
	Oct. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Summary of Debt Securities	As of October 31, 2022, debt securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value U.S. treasury securities $ 2,391,963 $ 1 $ (10,333) $ 2,381,631 U.S. agency obligations 548,109 — (6,020) 542,089 Corporate bonds 624,186 18 (11,877) 612,327 Commercial paper 1,054,938 — — 1,054,938 Total debt securities $ 4,619,196 $ 19 $ (28,230) $ 4,590,985 Included in Cash and cash equivalents $ 757,758 $ — $ (113) $ 757,645 Included in Marketable securities $ 3,861,438 $ 19 $ (28,117) $ 3,833,340 As of January 31, 2022, debt securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value U.S. treasury securities $ 843,627 $ 5 $ (1,720) $ 841,912 U.S. agency obligations 232,093 — (1,168) 230,925 Corporate bonds 490,867 — (1,815) 489,052 Commercial paper 969,204 — — 969,204 Total debt securities $ 2,535,791 $ 5 $ (4,703) $ 2,531,093 Included in Cash and cash equivalents $ 525,524 $ — $ (1) $ 525,523 Included in Marketable securities $ 2,010,267 $ 5 $ (4,702) $ 2,005,570
Equity Investments	Equity investments consisted of the following (in thousands): Condensed Consolidated Balance Sheets Location October 31, 2022 January 31, 2022 Money market funds Cash and cash equivalents $ 528,633 $ 607,640 Non-marketable equity investments measured using the measurement alternative Other assets 265,573 256,643 Marketable equity investments Marketable securities 82,790 104,318 Total equity investments $ 876,996 $ 968,601
Realized and Unrealized Gains and Losses With Equity Investments	Total realized and unrealized gains and losses associated with our equity investments consisted of the following (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Net realized gains (losses) recognized on equity investments sold (1) $ 4,514 $ 11,759 $ (365) $ 4,236 Net unrealized gains (losses) recognized on equity investments held as of the end of the period (155) 13,448 (19,121) 121,167 Total net gains (losses) recognized in Other income (expense), net $ 4,359 $ 25,207 $ (19,486) $ 125,403 (1) Reflects the difference between the sale proceeds and the carrying value of the equity investments at the beginning of the period.
Carrying Values Of Non-marketable Equity Investments	The carrying values for our non-marketable equity investments are summarized below (in thousands): October 31, 2022 January 31, 2022 Total initial cost $ 209,867 $ 192,694 Cumulative net unrealized gains (losses) 55,706 63,949 Carrying value $ 265,573 $ 256,643
Carrying Values Of Marketable Equity Investments	The carrying values for our marketable equity investments are summarized below (in thousands): October 31, 2022 January 31, 2022 Total initial cost $ 38,936 $ 40,739 Cumulative net unrealized gains (losses) 43,854 63,579 Carrying value $ 82,790 $ 104,318

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Information about Assets Measured at Fair Value on a Recurring Basis	The following table presents information about our assets and liabilities that are measured at fair value on a recurring basis and their assigned levels within the valuation hierarchy as of October 31, 2022 (in thousands): Level 1 Level 2 Level 3 Total U.S. treasury securities $ 2,381,631 $ — $ — $ 2,381,631 U.S. agency obligations — 542,089 — 542,089 Corporate bonds — 612,327 — 612,327 Commercial paper — 1,054,938 — 1,054,938 Money market funds 528,633 — — 528,633 Marketable equity investments 82,790 — — 82,790 Foreign currency derivative assets — 159,292 — 159,292 Total assets $ 2,993,054 $ 2,368,646 $ — $ 5,361,700 Foreign currency derivative liabilities $ — $ 36,486 $ — $ 36,486 Total liabilities $ — $ 36,486 $ — $ 36,486 The following table presents information about our assets and liabilities that are measured at fair value on a recurring basis and their assigned levels within the valuation hierarchy as of January 31, 2022 (in thousands): Level 1 Level 2 Level 3 Total U.S. treasury securities $ 841,912 $ — $ — $ 841,912 U.S. agency obligations — 230,925 — 230,925 Corporate bonds — 489,052 — 489,052 Commercial paper — 969,204 — 969,204 Money market funds 607,640 — — 607,640 Marketable equity investments 104,318 — — 104,318 Foreign currency derivative assets — 39,031 — 39,031 Total assets $ 1,553,870 $ 1,728,212 $ — $ 3,282,082 Foreign currency derivative liabilities $ — $ 13,039 $ — $ 13,039 Total liabilities $ — $ 13,039 $ — $ 13,039

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	9 Months Ended
	Oct. 31, 2022
Property, Plant and Equipment [Abstract]
Summary of Property and Equipment, Net	Property and equipment, net consisted of the following (in thousands): October 31, 2022 January 31, 2022 Computers, equipment, and software $ 1,292,126 $ 1,071,141 Buildings 718,495 691,896 Leasehold improvements 183,206 158,037 Furniture, fixtures, and transportation equipment 88,090 79,723 Land and land improvements 80,929 80,553 Property and equipment, gross 2,362,846 2,081,350 Less accumulated depreciation and amortization (1,143,719) (958,275) Property and equipment, net $ 1,219,127 $ 1,123,075

Acquisition-Related Intangibl_2

Acquisition-Related Intangible Assets, Net (Tables)	9 Months Ended
	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Acquired Assets	Acquisition-related intangible assets, net consisted of the following (in thousands): October 31, 2022 January 31, 2022 Developed technology $ 346,300 $ 346,300 Customer relationships 311,100 311,100 Backlog 15,000 15,000 Trade name 12,500 12,500 Acquisition-related intangible assets, gross 684,900 684,900 Less accumulated amortization (358,230) (293,898) Acquisition-related intangible assets, net $ 326,670 $ 391,002
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of October 31, 2022, our future estimated amortization expense related to acquisition-related intangible assets was as follows (in thousands): Fiscal Period: Remainder of 2023 $ 21,204 2024 74,319 2025 61,663 2026 55,748 2027 31,177 Thereafter 82,559 Total $ 326,670 Fiscal Period: Remainder of 2023 $ 853 2024 3,172 2025 2,689 2026 2,434 2027 2,150 Thereafter 9,623 Total $ 20,921

Other Assets (Tables)

Other Assets (Tables)	9 Months Ended
	Oct. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Other Noncurrent Assets	Other noncurrent assets consisted of the following (in thousands): October 31, 2022 January 31, 2022 Non-marketable equity and other investments $ 268,543 $ 256,759 Derivative assets 71,482 16,618 Technology patents and other intangible assets, net 20,921 22,792 Prepayments for goods and services 18,767 25,927 Net deferred tax assets 9,441 11,642 Deposits 5,345 6,701 Other 11,438 813 Total other assets $ 405,937 $ 341,252
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of October 31, 2022, our future estimated amortization expense related to acquisition-related intangible assets was as follows (in thousands): Fiscal Period: Remainder of 2023 $ 21,204 2024 74,319 2025 61,663 2026 55,748 2027 31,177 Thereafter 82,559 Total $ 326,670 Fiscal Period: Remainder of 2023 $ 853 2024 3,172 2025 2,689 2026 2,434 2027 2,150 Thereafter 9,623 Total $ 20,921

Derivative Instruments (Tables)

Derivative Instruments (Tables)	9 Months Ended
	Oct. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair Values of Outstanding Derivative Instruments	The fair values of outstanding derivative instruments were as follows (in thousands): Condensed Consolidated Balance Sheets Location October 31, 2022 January 31, 2022 Derivative assets: Cash flow hedges Prepaid expenses and other current assets $ 86,853 $ 21,337 Cash flow hedges Other assets 71,480 16,618 Non-designated hedges Prepaid expenses and other current assets 957 1,076 Non-designated hedges Other assets 2 — Total derivative assets $ 159,292 $ 39,031 Derivative liabilities: Cash flow hedges Accrued expenses and other current liabilities $ 31,331 $ 7,512 Cash flow hedges Other liabilities 1,500 5,175 Non-designated hedges Accrued expenses and other current liabilities 3,655 336 Non-designated hedges Other liabilities — 16 Total derivative liabilities $ 36,486 $ 13,039
Derivative Instruments Gain (Loss)	The effect of cash flow hedges on the Condensed Consolidated Statements of Operations was as follows (in thousands): Three Months Ended October 31, 2022 2021 Revenues Costs and Expenses Income Tax Revenues Costs and Expenses Income Tax Total $ 1,599,103 $ 1,625,424 $ 52,563 $ 1,327,263 $ 1,303,318 $ 2,090 Gains (losses) related to cash flow hedges 5,647 (11,852) (3,220) (3,847) — — Nine Months Ended October 31, 2022 2021 Revenues Costs and Expenses Income Tax Revenues Costs and Expenses Income Tax Total $ 4,569,558 $ 4,702,800 $ 59,021 $ 3,762,657 $ 3,778,145 $ (2,623) Gains (losses) related to cash flow hedges 5,985 (18,636) (3,220) (4,996) — — Gains (losses) associated with cash flow hedges were as follows (in thousands): Consolidated Statements of Operations and Statements of Comprehensive Income (Loss) Locations Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Gains (losses) recognized in OCI Net change in unrealized gains (losses) on cash flow hedges $ 48,058 $ 21,542 $ 110,052 $ 33,320 Gains (losses) reclassified from AOCI into income (effective portion) Revenues 5,647 (3,847) 5,985 (4,996) Gains (losses) reclassified from AOCI into income (effective portion) Costs and expenses (11,852) — (18,636) — Gains (losses) reclassified from AOCI into income (effective portion) Income Tax (3,220) — (3,220) — Gains (losses) associated with non-designated hedges were as follows (in thousands): Condensed Consolidated Statements of Operations Location Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Gains (losses) related to non-designated hedges Other income (expense), net $ 7,187 $ 605 $ 13,288 $ 2,424
Offsetting Assets	As of October 31, 2022, information related to these offsetting arrangements was as follows (in thousands): Gross Amounts of Recognized Assets Gross Amounts Offset on the Condensed Consolidated Balance Sheets Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets Net Assets Exposed Financial Instruments Cash Collateral Received Derivative assets: Counterparty A $ 30,677 $ — $ 30,677 $ (879) $ — $ 29,798 Counterparty B 33,589 — 33,589 (19,020) — 14,569 Counterparty C 14,153 — 14,153 (7,956) — 6,197 Counterparty D 72,310 — 72,310 (8,143) — 64,167 Counterparty E 8,563 — 8,563 (488) — 8,075 Total $ 159,292 $ — $ 159,292 $ (36,486) $ — $ 122,806
Offsetting Liabilities	Gross Amounts of Recognized Liabilities Gross Amounts Offset on the Condensed Consolidated Balance Sheets Net Amounts of Liabilities Presented on the Condensed Consolidated Balance Sheets Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets Net Liabilities Exposed Financial Instruments Cash Collateral Pledged Derivative liabilities: Counterparty A $ 879 $ — $ 879 $ (879) $ — $ — Counterparty B 19,020 — 19,020 (19,020) — — Counterparty C 7,956 — 7,956 (7,956) — — Counterparty D 8,143 — 8,143 (8,143) — — Counterparty E 488 — 488 (488) — — Total $ 36,486 $ — $ 36,486 $ (36,486) $ — $ —

Debt (Tables)

Debt (Tables)	9 Months Ended
	Oct. 31, 2022
Debt Disclosure [Abstract]
Outstanding Debt	Outstanding debt consisted of the following (in thousands): October 31, 2022 January 31, 2022 2027 Notes $ 1,000,000 $ — 2029 Notes 750,000 — 2032 Notes 1,250,000 — 2022 Notes — 1,149,817 Term loan under the 2020 Credit Agreement — 693,750 Total principal amount 3,000,000 1,843,567 Less: unamortized debt discount and issuance costs (25,021) (3,770) Net carrying amount 2,974,979 1,839,797 Less: debt, current — (1,222,443) Debt, noncurrent $ 2,974,979 $ 617,354
Schedule of Maturities of Long-term Debt	As of October 31, 2022, the future principal payments for the outstanding debt were as follows (in thousands): Fiscal Period: Remainder of 2023 $ — 2024 — 2025 — 2026 — 2027 — Thereafter 3,000,000 Total principal amount $ 3,000,000
Schedule of Interest Expense	The following table sets forth total interest expense recognized related to our debt (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Contractual interest expense $ 28,036 $ 3,140 $ 67,702 $ 9,462 Interest cost related to amortization and write-off of debt discount and issuance costs 1,557 997 6,000 2,991 Total interest expense $ 29,593 $ 4,137 $ 73,702 $ 12,453

Leases (Tables)

Leases (Tables)	9 Months Ended
	Oct. 31, 2022
Leases [Abstract]
Components of Lease Expense	The components of operating lease expense were as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Operating lease cost $ 25,404 $ 22,988 $ 73,821 $ 70,004 Short-term lease cost 854 1,204 3,001 5,419 Variable lease cost 12,787 8,756 32,970 18,519 Total operating lease cost $ 39,045 $ 32,948 $ 109,792 $ 93,942
Information Related to Right-of-Use Assets and Lease Liabilities	Supplemental cash flow information related to our operating leases was as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Cash paid for operating lease liabilities $ 23,190 $ 21,802 $ 68,386 $ 68,375 Operating lease right-of-use assets obtained in exchange for new operating lease liabilities 6,611 15,646 93,091 54,335 Other information related to our operating leases was as follows: October 31, 2022 January 31, 2022 Weighted average remaining lease term (in years) 5 5 Weighted average discount rate 2.74 % 2.35 %
Maturities of Operating Lease Liabilities	As of October 31, 2022, maturities of operating lease liabilities were as follows (in thousands): Fiscal Period: Remainder of 2023 $ 26,000 2024 93,305 2025 76,088 2026 47,332 2027 26,790 Thereafter 45,548 Total lease payments 315,063 Less imputed interest (28,748) Total operating lease liabilities $ 286,315

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Oct. 31, 2022
Equity [Abstract]
Summary of Information Related to Restricted Stock Units Activity	A summary of information related to RSU activity during the nine months ended October 31, 2022, is as follows (in thousands, except per share data): Number of Shares Weighted-Average Grant Date Fair Value Balance as of January 31, 2022 11,808 $ 209.12 RSUs granted 8,198 205.45 RSUs vested (4,298) 202.82 RSUs forfeited (1,071) 205.52 Balance as of October 31, 2022 14,637 209.18
Summary of Information Related to Stock Option Activity	A summary of information related to stock option activity during the nine months ended October 31, 2022, is as follows (in millions, except number of shares which are reflected in thousands and per share data): Outstanding Stock Options Weighted-Average Exercise Price Aggregate Intrinsic Value Balance as of January 31, 2022 387 $ 20.09 $ 90 Stock options exercised (212) 13.46 Stock options canceled (45) 16.20 Balance as of October 31, 2022 130 32.20 16 Vested and expected to vest as of October 31, 2022 130 32.20 16 Exercisable as of October 31, 2022 130 32.16 16

Other Income (Expense), Net (Ta

Other Income (Expense), Net (Tables)	9 Months Ended
	Oct. 31, 2022
Other Income and Expenses [Abstract]
Other Income (Expense), Net	Other income (expense), net consisted of the following (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Interest income $ 31,252 $ 1,195 $ 50,473 $ 4,531 Interest expense (1) (29,626) (4,160) (73,804) (12,527) Other (2) 2,537 24,522 (25,458) 123,487 Total other income (expense), net $ 4,163 $ 21,557 $ (48,789) $ 115,491 (1) Interest expense primarily includes the contractual interest expense of our debt obligations, and the related non-cash interest expense attributable to amortization of the debt discount and issuance costs. For further information, see Note 10, Debt . (2) Other primarily includes the net gains (losses) from our equity investments. For further information, see Note 3, Investments .

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	9 Months Ended
	Oct. 31, 2022
Earnings Per Share [Abstract]
Summary of Calculation of Basic and Diluted Net Income (Loss) Per Share	The following table presents the calculation of basic and diluted net income (loss) per share (in thousands, except per share data): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Class A Class B Class A Class B Class A Class B Class A Class B Net income (loss) per share, basic: Numerator: Net income (loss) $ (58,648) $ (16,073) $ 33,417 $ 9,995 $ (188,757) $ (52,295) $ 78,546 $ 24,080 Denominator: Weighted-average shares outstanding, basic 200,740 55,013 191,259 57,209 198,876 55,099 188,546 57,802 Net income (loss) per share, basic $ (0.29) $ (0.29) $ 0.17 $ 0.17 $ (0.95) $ (0.95) $ 0.42 $ 0.42 Net income (loss) per share, diluted: Numerator: Net income (loss) $ (58,648) $ (16,073) $ 33,417 $ 9,995 $ (188,757) $ (52,295) $ 78,546 $ 24,080 Reallocation of net income as a result of conversion of Class B to Class A common stock — — 9,995 — — — 24,080 — Reallocation of net income to Class B common stock — — — (247) — — — (718) Net income (loss) for diluted calculation (58,648) (16,073) 43,412 9,748 (188,757) (52,295) 102,626 23,362 Denominator: Weighted-average shares outstanding, basic 200,740 55,013 191,259 57,209 198,876 55,099 188,546 57,802 Conversion of Class B to Class A common stock — — 57,209 — — — 57,802 — Dilutive effect of share-based awards — — 4,933 — — — 6,456 — Dilutive effect of warrants related to the issuance of convertible senior notes — — 1,359 — — — 1,113 — Weighted-average shares outstanding, diluted 200,740 55,013 254,760 57,209 198,876 55,099 253,917 57,802 Net income (loss) per share, diluted $ (0.29) $ (0.29) $ 0.17 $ 0.17 $ (0.95) $ (0.95) $ 0.40 $ 0.40
Shares Excluded from Diluted Net Income (Loss) Per Share	The effects of these potentially outstanding shares were not included in the calculation of diluted net income (loss) per share because the effect would have been anti-dilutive (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 Shares related to outstanding share-based awards 16,105 151 15,453 1,801 Shares related to the convertible senior notes 5,182 7,817 6,928 7,817 Shares subject to warrants related to the issuance of convertible senior notes 7,818 — 7,818 — Total 29,105 7,968 30,199 9,618

Geographic Information (Tables)

Geographic Information (Tables)	9 Months Ended
	Oct. 31, 2022
Segment Reporting [Abstract]
Summary of Revenues by Geographic Area	The following table sets forth revenues by geographic area (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2022 2021 2022 2021 United States $ 1,204,842 $ 991,747 $ 3,432,249 $ 2,817,749 Other countries 394,261 335,516 1,137,309 944,908 Total revenues $ 1,599,103 $ 1,327,263 $ 4,569,558 $ 3,762,657
Long-lived Assets by Geographic Areas	Aggregate Property and equipment, net and Operating lease right-of-use assets by geographic area was as follows (in thousands): October 31, 2022 January 31, 2022 United States $ 1,243,176 $ 1,174,371 Ireland 158,975 117,049 Other countries 85,086 79,463 Total long-lived assets $ 1,487,237 $ 1,370,883

Overview and Basis of Present_3

Overview and Basis of Presentation (Detail)	9 Months Ended
	Oct. 31, 2022 segment
Accounting Policies [Abstract]
Number of operating segments	1

Investments - Summary of Market

Investments - Summary of Marketable Securities (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 4,619,196	$ 2,535,791
Unrealized Gains	19	5
Unrealized Losses	(28,230)	(4,703)
Aggregate Fair Value	4,590,985	2,531,093
Included in Cash and cash equivalents
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	757,758	525,524
Unrealized Gains	0	0
Unrealized Losses	(113)	(1)
Aggregate Fair Value	757,645	525,523
Included in Marketable securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	3,861,438	2,010,267
Unrealized Gains	19	5
Unrealized Losses	(28,117)	(4,702)
Aggregate Fair Value	3,833,340	2,005,570
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	2,391,963	843,627
Unrealized Gains	1	5
Unrealized Losses	(10,333)	(1,720)
Aggregate Fair Value	2,381,631	841,912
U.S. agency obligations
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	548,109	232,093
Unrealized Gains	0	0
Unrealized Losses	(6,020)	(1,168)
Aggregate Fair Value	542,089	230,925
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	624,186	490,867
Unrealized Gains	18	0
Unrealized Losses	(11,877)	(1,815)
Aggregate Fair Value	612,327	489,052
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1,054,938	969,204
Unrealized Gains	0	0
Unrealized Losses	0	0
Aggregate Fair Value	$ 1,054,938	$ 969,204

Investments - Narrative (Detail

Investments - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022
Schedule of Equity Method Investments [Line Items]
Fair value of debt securities in an unrealized loss position	$ 3,500		$ 3,500		$ 1,500
Credit and non-credit losses on debt securities	0	$ 0	0	$ 0
Proceeds of sale of debt securities	20	0	48	10
Upward price adjustment to non-marketable equity investments	2	20	8	34
Impairment loss on non-marketable equity securities	2		10	2
Gain (loss) on non-marketable equity securities	4		(2)
Gain on sale of equity securities marketable equity investments			1
Proceeds from sale of available-for-sale securities, equity	0	0	5	17
Loss on sale of equity securities marketable equity investments				6
Equity securities, unrealized gain	0			91
Equity securities, unrealized loss	$ 0	7	$ 17
Zimit, Inc.
Schedule of Equity Method Investments [Line Items]
Gain on sale of equity securities marketable equity investments		$ 12		$ 12

Investments - Equity Investment

Investments - Equity Investments (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Schedule of Equity Method Investments [Line Items]
Non-marketable equity investments measured using the measurement alternative	$ 265,573	$ 256,643
Equity investments	876,996	968,601
Cash and cash equivalents
Schedule of Equity Method Investments [Line Items]
Equity securities	528,633	607,640
Other assets
Schedule of Equity Method Investments [Line Items]
Non-marketable equity investments measured using the measurement alternative	265,573	256,643
Marketable securities
Schedule of Equity Method Investments [Line Items]
Equity securities	$ 82,790	$ 104,318

Investments - Equity Investme_2

Investments - Equity Investments Realized and Unrealized Gains (Losses) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Net realized gains (losses) recognized on equity investments sold	$ 4,514	$ 11,759	$ (365)	$ 4,236
Net unrealized gains (losses) recognized on equity investments held as of the end of the period	(155)	13,448	(19,121)	121,167
Total net gains (losses) recognized in Other income (expense), net	$ 4,359	$ 25,207	$ (19,486)	$ 125,403

Investments - Schedule of Non-M

Investments - Schedule of Non-Marketable Equity Investments (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Total initial cost	$ 209,867	$ 192,694
Cumulative net unrealized gains (losses)	55,706	63,949
Carrying value	$ 265,573	$ 256,643

Investments - Schedule of Marke

Investments - Schedule of Marketable Equity Investments (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Debt and Equity Securities, FV-NI [Line Items]
Total initial cost	$ 38,936	$ 40,739
Cumulative net unrealized gains (losses)	43,854	63,579
Marketable securities
Debt and Equity Securities, FV-NI [Line Items]
Equity securities	$ 82,790	$ 104,318

Fair Value Measurements - Infor

Fair Value Measurements - Information about Assets Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	$ 4,590,985	$ 2,531,093
Foreign currency derivative assets	159,292
Foreign currency derivative liabilities	36,486
U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	2,381,631	841,912
U.S. agency obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	542,089	230,925
Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	612,327	489,052
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	1,054,938	969,204
Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable equity investments	82,790	104,318
Foreign currency derivative assets	159,292	39,031
Total assets	5,361,700	3,282,082
Foreign currency derivative liabilities	36,486	13,039
Total liabilities	36,486	13,039
Fair Value, Measurements, Recurring | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	2,381,631	841,912
Fair Value, Measurements, Recurring | U.S. agency obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	542,089	230,925
Fair Value, Measurements, Recurring | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	612,327	489,052
Fair Value, Measurements, Recurring | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	1,054,938	969,204
Fair Value, Measurements, Recurring | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	528,633	607,640
Fair Value, Measurements, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable equity investments	82,790	104,318
Foreign currency derivative assets	0	0
Total assets	2,993,054	1,553,870
Foreign currency derivative liabilities	0	0
Total liabilities	0	0
Fair Value, Measurements, Recurring | Level 1 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	2,381,631	841,912
Fair Value, Measurements, Recurring | Level 1 | U.S. agency obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Level 1 | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Level 1 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	528,633	607,640
Fair Value, Measurements, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable equity investments	0	0
Foreign currency derivative assets	159,292	39,031
Total assets	2,368,646	1,728,212
Foreign currency derivative liabilities	36,486	13,039
Total liabilities	36,486	13,039
Fair Value, Measurements, Recurring | Level 2 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Level 2 | U.S. agency obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	542,089	230,925
Fair Value, Measurements, Recurring | Level 2 | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	612,327	489,052
Fair Value, Measurements, Recurring | Level 2 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	1,054,938	969,204
Fair Value, Measurements, Recurring | Level 2 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	0	0
Fair Value, Measurements, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable equity investments	0	0
Foreign currency derivative assets	0	0
Total assets	0	0
Foreign currency derivative liabilities	0	0
Total liabilities	0	0
Fair Value, Measurements, Recurring | Level 3 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Level 3 | U.S. agency obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Level 3 | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Level 3 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Level 3 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market funds	$ 0	$ 0

Deferred Costs (Details)

Deferred Costs (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022
Revenue from Contract with Customer [Abstract]
Deferred sales commission	$ 531		$ 531		$ 494
Amortization of deferred costs	45	$ 36	127	$ 101
Capitalized contract cost, impairment loss	$ 0	$ 0	$ 0	$ 0

Property and Equipment, Net - S

Property and Equipment, Net - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 2,362,846	$ 2,081,350
Less accumulated depreciation and amortization	(1,143,719)	(958,275)
Property and equipment, net	1,219,127	1,123,075
Computers, equipment, and software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,292,126	1,071,141
Buildings
Property, Plant and Equipment [Line Items]
Property and equipment, gross	718,495	691,896
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	183,206	158,037
Furniture, fixtures, and transportation equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	88,090	79,723
Land and land improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 80,929	$ 80,553

Property and Equipment, Net - N

Property and Equipment, Net - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 69	$ 66	$ 207	$ 194

Acquisition-Related Intangibl_3

Acquisition-Related Intangible Assets, Net - Schedule of Acquired Assets (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022
Acquisition-related intangible assets
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 684,900		$ 684,900		$ 684,900
Less accumulated amortization	(358,230)		(358,230)		(293,898)
Total	326,670		326,670		391,002
Amortization of intangible assets	21,000	$ 19,000	64,000	$ 57,000
Developed technology
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	346,300		346,300		346,300
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	311,100		311,100		311,100
Backlog
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	15,000		15,000		15,000
Trade name
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 12,500		$ 12,500		$ 12,500

Acquisition-Related Intangibl_4

Acquisition-Related Intangible Assets, Net - Schedule of Future Amortization Expense (Detail) - Acquisition-related intangible assets - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Remainder of 2023	$ 21,204
2024	74,319
2025	61,663
2026	55,748
2027	31,177
Thereafter	82,559
Total	$ 326,670	$ 391,002

Other Assets - Schedule of Othe

Other Assets - Schedule of Other Noncurrent Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Other Assets [Line Items]
Non-marketable equity and other investments	$ 268,543	$ 256,759
Derivative assets	71,482	16,618
Prepayments for goods and services	18,767	25,927
Net deferred tax assets	9,441	11,642
Deposits	5,345	6,701
Other	11,438	813
Total other assets	405,937	341,252
Technology patents and other intangible assets, net
Other Assets [Line Items]
Technology patents and other intangible assets, net	$ 20,921	$ 22,792

Other Assets - Summary of Futur

Other Assets - Summary of Future Estimated Amortization Expense Related to Acquired Land Leasehold Interest and Technology Patents (Details) - Technology patents and other intangible assets, net - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Remainder of 2023	$ 853
2024	3,172
2025	2,689
2026	2,434
2027	2,150
Thereafter	9,623
Total	$ 20,921	$ 22,792

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Oct. 31, 2022	Jan. 31, 2022
Derivative [Line Items]
Net gains on cash flow hedges estimated to be reclassified into income within the next 12 months	$ 39
Non-designated hedges | Long
Derivative [Line Items]
Derivative, notional amount	127	$ 217
Non-designated hedges | Short
Derivative [Line Items]
Derivative, notional amount	34	8
Cash flow hedges | Cash flow hedges | Long
Derivative [Line Items]
Derivative, notional amount	1,600	1,400
Cash flow hedges | Cash flow hedges | Short
Derivative [Line Items]
Derivative, notional amount	$ 365	$ 355
Cash flow hedges | Cash flow hedges | Maximum
Derivative [Line Items]
Derivative, remaining maturity (in months)	48 months

Derivative Instruments - Fair V

Derivative Instruments - Fair Values of Outstanding Derivative Instruments (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Derivatives, Fair Value [Line Items]
Derivative assets:	$ 159,292	$ 39,031
Derivative liabilities:	36,486	13,039
Non-designated hedges | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Derivative assets:	957	1,076
Non-designated hedges | Other assets
Derivatives, Fair Value [Line Items]
Derivative assets:	2	0
Non-designated hedges | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liabilities:	3,655	336
Non-designated hedges | Other liabilities
Derivatives, Fair Value [Line Items]
Derivative liabilities:	0	16
Cash flow hedges | Cash flow hedges | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Derivative assets:	86,853	21,337
Cash flow hedges | Cash flow hedges | Other assets
Derivatives, Fair Value [Line Items]
Derivative assets:	71,480	16,618
Cash flow hedges | Cash flow hedges | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Derivative liabilities:	31,331	7,512
Cash flow hedges | Cash flow hedges | Other liabilities
Derivatives, Fair Value [Line Items]
Derivative liabilities:	$ 1,500	$ 5,175

Derivative Instruments - Effect

Derivative Instruments - Effect of Cash Flow Hedges on Income Statement (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Total	$ 1,599,103	$ 1,327,263	$ 4,569,558	$ 3,762,657
Total costs and expenses	1,625,424	1,303,318	4,702,800	3,778,145
Total income tax	52,563	2,090	59,021	(2,623)
Income Tax	(3,220)	0	(3,220)	0
Revenues
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) related to cash flow hedges	5,647	(3,847)	5,985	(4,996)
Costs and Expenses
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) related to cash flow hedges	$ (11,852)	$ 0	$ (18,636)	$ 0

Derivative Instruments - Pre-ta

Derivative Instruments - Pre-tax Gains (Losses) Associated with Cash Flow Hedges (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) recognized in OCI	$ 48,058	$ 21,542	$ 110,052	$ 33,320
Income Tax	(3,220)	0	(3,220)	0
Revenues
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) reclassified from AOCI into income (effective portion)	5,647	(3,847)	5,985	(4,996)
Costs and expenses
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) reclassified from AOCI into income (effective portion)	(11,852)	0	(18,636)	0
Other income (expense), net
Derivative Instruments, Gain (Loss) [Line Items]
Gains (losses) related to non-designated hedges	$ 7,187	$ 605	$ 13,288	$ 2,424

Derivative Instruments - Offset

Derivative Instruments - Offsetting Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Offsetting Assets [Line Items]
Gross Amounts of Recognized Assets	$ 159,292	$ 39,031
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets	159,292
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(36,486)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0
Net Assets Exposed	122,806
Counterparty A
Offsetting Assets [Line Items]
Gross Amounts of Recognized Assets	30,677
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets	30,677
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(879)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0
Net Assets Exposed	29,798
Counterparty B
Offsetting Assets [Line Items]
Gross Amounts of Recognized Assets	33,589
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets	33,589
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(19,020)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0
Net Assets Exposed	14,569
Counterparty C
Offsetting Assets [Line Items]
Gross Amounts of Recognized Assets	14,153
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets	14,153
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(7,956)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0
Net Assets Exposed	6,197
Counterparty D
Offsetting Assets [Line Items]
Gross Amounts of Recognized Assets	72,310
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets	72,310
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(8,143)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0
Net Assets Exposed	64,167
Counterparty E
Offsetting Assets [Line Items]
Gross Amounts of Recognized Assets	8,563
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Assets Presented on the Condensed Consolidated Balance Sheets	8,563
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(488)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Received	0
Net Assets Exposed	$ 8,075

Derivative Instruments - Offs_2

Derivative Instruments - Offsetting Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Offsetting Liabilities [Line Items]
Gross Amounts of Recognized Liabilities	$ 36,486	$ 13,039
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Liabilities Presented on the Condensed Consolidated Balance Sheets	36,486
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(36,486)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Pledged	0
Net Liabilities Exposed	0
Counterparty A
Offsetting Liabilities [Line Items]
Gross Amounts of Recognized Liabilities	879
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Liabilities Presented on the Condensed Consolidated Balance Sheets	879
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(879)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Pledged	0
Net Liabilities Exposed	0
Counterparty B
Offsetting Liabilities [Line Items]
Gross Amounts of Recognized Liabilities	19,020
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Liabilities Presented on the Condensed Consolidated Balance Sheets	19,020
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(19,020)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Pledged	0
Net Liabilities Exposed	0
Counterparty C
Offsetting Liabilities [Line Items]
Gross Amounts of Recognized Liabilities	7,956
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Liabilities Presented on the Condensed Consolidated Balance Sheets	7,956
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(7,956)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Pledged	0
Net Liabilities Exposed	0
Counterparty D
Offsetting Liabilities [Line Items]
Gross Amounts of Recognized Liabilities	8,143
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Liabilities Presented on the Condensed Consolidated Balance Sheets	8,143
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(8,143)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Pledged	0
Net Liabilities Exposed	0
Counterparty E
Offsetting Liabilities [Line Items]
Gross Amounts of Recognized Liabilities	488
Gross Amounts Offset on the Condensed Consolidated Balance Sheets	0
Net Amounts of Liabilities Presented on the Condensed Consolidated Balance Sheets	488
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Financial Instruments	(488)
Gross Amounts Not Offset on the Condensed Consolidated Balance Sheets, Cash Collateral Pledged	0
Net Liabilities Exposed	$ 0

Debt - Outstanding Debt (Detail

Debt - Outstanding Debt (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Debt Instrument [Line Items]
Long-term debt, gross	$ 3,000,000	$ 1,843,567
Less: unamortized debt discount and issuance costs	(25,021)	(3,770)
Net carrying amount	2,974,979	1,839,797
Less: debt, current	0	(1,222,443)
Debt, noncurrent	2,974,979	617,354
2027 Notes
Debt Instrument [Line Items]
Long-term debt, gross	1,000,000	0
2029 Notes
Debt Instrument [Line Items]
Long-term debt, gross	750,000	0
2032 Notes
Debt Instrument [Line Items]
Long-term debt, gross	1,250,000	0
2022 Notes
Debt Instrument [Line Items]
Long-term debt, gross	0	1,149,817
Term loan under the 2020 Credit Agreement
Debt Instrument [Line Items]
Long-term debt, gross	$ 0	$ 693,750

Debt - Schedule of Maturities o

Debt - Schedule of Maturities of Long-term Debt (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Debt Disclosure [Abstract]
Remainder of 2023	$ 0
2024	0
2025	0
2026	0
2027	0
Thereafter	3,000,000
Total principal amount	$ 3,000,000	$ 1,843,567

Debt - Senior Notes, Credit Agr

Debt - Senior Notes, Credit Agreement, Convertible Senior Notes, Notes Hedges and Warrants (Details) $ / shares in Units, shares in Millions	1 Months Ended	3 Months Ended	9 Months Ended
	Apr. 30, 2022 USD ($)	Oct. 31, 2022 USD ($) $ / shares shares	Oct. 31, 2022 USD ($) trading_day $ / shares shares	Jan. 31, 2022 USD ($)	Apr. 30, 2020 USD ($)	Sep. 30, 2017 USD ($)
Debt Instrument [Line Items]
Debt discount and issuance costs		$ 25,021,000	$ 25,021,000	$ 3,770,000
Number of trading days related to warrants (in days) | trading_day			60
Warrants expires In 2023
Debt Instrument [Line Items]
Shares covered by each purchased options or warrants (in shares) | shares		7.8	7.8
Number of trading days related to warrants (in days) | trading_day			60
Exercise price of warrants (in dollars per share) | $ / shares		$ 213.96	$ 213.96
Senior Notes
Debt Instrument [Line Items]
Principal	$ 3,000,000,000
Debt discount and issuance costs	27,000,000
Fair value of Senior Notes		$ 2,700,000,000	$ 2,700,000,000
2027 Notes | Senior Notes
Debt Instrument [Line Items]
Principal	$ 1,000,000,000
Contractual interest rate	3.50%
Effective interest rate		3.67%	3.67%
2029 Notes | Senior Notes
Debt Instrument [Line Items]
Principal	$ 750,000,000
Contractual interest rate	3.70%
Effective interest rate		3.82%	3.82%
2032 Notes | Senior Notes
Debt Instrument [Line Items]
Principal	$ 1,250,000,000
Contractual interest rate	3.80%
Effective interest rate		3.90%	3.90%
2022 Credit Agreement
Debt Instrument [Line Items]
Debt instrument, maximum leverage ratio			3.50
Debt instrument, maximum leverage ratio step up			4.50
2022 Credit Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 1,000,000,000
Long-term line of credit		$ 0	$ 0
2020 Credit Agreement | Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity					$ 750,000,000
Long-term line of credit	0
Term loan under the 2020 Credit Agreement | Term Loan
Debt Instrument [Line Items]
Principal					$ 750,000,000
Remaining principal paid off	$ 694,000,000
2022 Notes
Debt Instrument [Line Items]
Repayments on convertible senior notes		$ 1,150,000,000
2022 Notes | Convertible Debt
Debt Instrument [Line Items]
Principal						$ 1,150,000,000
Contractual interest rate						0.25%
2022 Notes | Convertible Debt | Class A
Debt Instrument [Line Items]
Settlement of convertible senior notes (in shares) | shares		0.6
Indexed shares (in shares) | shares		7.8	7.8
Initial conversion price (in dollars per share) | $ / shares		$ 147.10	$ 147.10
Purchase of treasury stock from the exercise of convertible senior notes hedges (in shares) | shares		0.6
Base Rate | Minimum | 2022 Credit Agreement
Debt Instrument [Line Items]
Basis spread on variable rate			0%
Base Rate | Maximum | 2022 Credit Agreement
Debt Instrument [Line Items]
Basis spread on variable rate			0.50%
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | 2022 Credit Agreement
Debt Instrument [Line Items]
Basis spread on variable rate			0.10%
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Minimum | 2022 Credit Agreement
Debt Instrument [Line Items]
Basis spread on variable rate			0.75%
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Maximum | 2022 Credit Agreement
Debt Instrument [Line Items]
Basis spread on variable rate			1.50%

Debt - Schedule of Interest Exp

Debt - Schedule of Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Debt Disclosure [Abstract]
Contractual interest expense	$ 28,036	$ 3,140	$ 67,702	$ 9,462
Interest cost related to amortization and write-off of debt discount and issuance costs	1,557	997	6,000	2,991
Total interest expense	$ 29,593	$ 4,137	$ 73,702	$ 12,453

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Lessee, Lease, Description [Line Items]
Operating lease right-of-use assets	$ 268,110	$ 247,808
Operating lease liabilities	286,315	$ 263,000
Operating lease, lease not yet commenced, payment	$ 52,000
Minimum
Lessee, Lease, Description [Line Items]
Operating lease, lease not yet commenced, term (years)	5 years
Maximum
Lessee, Lease, Description [Line Items]
Operating lease, lease not yet commenced, term (years)	6 years

Leases - Components of Lease Ex

Leases - Components of Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Leases [Abstract]
Operating lease cost	$ 25,404	$ 22,988	$ 73,821	$ 70,004
Short-term lease cost	854	1,204	3,001	5,419
Variable lease cost	12,787	8,756	32,970	18,519
Total operating lease cost	$ 39,045	$ 32,948	$ 109,792	$ 93,942

Leases - Information Related to

Leases - Information Related to Our Right-of-Use Assets and Lease Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022
Leases [Abstract]
Cash paid for operating lease liabilities	$ 23,190	$ 21,802	$ 68,386	$ 68,375
Operating lease right-of-use assets obtained in exchange for new operating lease liabilities	$ 6,611	$ 15,646	$ 93,091	$ 54,335
Weighted average remaining lease term (in years)	5 years		5 years		5 years
Weighted average discount rate	2.74%		2.74%		2.35%

Leases - Maturities of Operatin

Leases - Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
Remainder of 2023	$ 26,000
2024	93,305
2025	76,088
2026	47,332
2027	26,790
Thereafter	45,548
Total lease payments	315,063
Less imputed interest	(28,748)
Total operating lease liabilities	$ 286,315	$ 263,000

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 31, 2022 USD ($) shares	Oct. 31, 2021 USD ($)	Oct. 31, 2022 USD ($) vote shares	Oct. 31, 2021 USD ($)	Jan. 31, 2022 shares	Jun. 22, 2022 shares	Mar. 31, 2022 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation expenses | $	$ 314,196	$ 281,118	$ 933,709	$ 810,472
2022 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved for future issuance (in shares)						30,000,000
Common stock available for future grants (in shares)	29,000,000		29,000,000
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock available for future grants (in shares)	5,000,000		5,000,000
Increase to share ESPP share reserve (in shares)							2,000,000
Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of fair market value of stock at which employees are granted shares			85%
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period of vesting (in years)			4 years
Unrecognized compensation cost, other than options | $	$ 2,300,000		$ 2,300,000
Unrecognized compensation cost recognized over weighted-average period (in years)			3 years
RSUs granted (in shares)			8,198,000
Performance Based Restricted Stock Unit PRSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSUs granted (in shares)			0
Performance Based Restricted Stock Unit PRSU | Non-Executive Employees | Vesting March 15 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSUs granted (in shares)					400,000
Total share-based compensation expenses | $			$ 16,000
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period of vesting (in years)			5 years
Period of which options become exercisable (in years)			10 years
Class A
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, outstanding (in shares)	202,000,000		202,000,000
Common stock, votes per share | vote			1
Class B
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, outstanding (in shares)	55,000,000		55,000,000
Common stock, votes per share | vote			10

Stockholders' Equity - Restrict

Stockholders' Equity - Restricted Stock Units Activity (Details) - Restricted Stock Units	9 Months Ended
	Oct. 31, 2022 $ / shares shares
Number of Shares
Beginning Balance (in shares) | shares	11,808,000
RSUs granted (in shares) | shares	8,198,000
RSUs vested (in shares) | shares	(4,298,000)
RSUs forfeited (in shares) | shares	(1,071,000)
Ending Balance (in shares) | shares	14,637,000
Weighted-Average Grant Date Fair Value
Beginning Balance (in dollars per share) | $ / shares	$ 209.12
RSUs granted (in dollars per share) | $ / shares	205.45
RSUs vested (in dollars per share) | $ / shares	202.82
RSUs forfeited (in dollars per share) | $ / shares	205.52
Ending Balance (in dollars per share) | $ / shares	$ 209.18

Stockholders' Equity - Stock Op

Stockholders' Equity - Stock Options (Details) $ / shares in Units, $ in Millions	9 Months Ended
	Oct. 31, 2022 USD ($) $ / shares shares
Outstanding Stock Options
Beginning Balance (in shares) | shares	387,000
Stock options exercised (in shares) | shares	(212,000)
Stock options canceled (in shares) | shares	(45,000)
Ending Balance (in shares) | shares	130,000
Vested and expected to vest (in shares) | shares	130,000
Exercisable (in shares) | shares	130,000
Weighted-Average Exercise Price
Beginning Balance (in dollars per share) | $ / shares	$ 20.09
Stock options exercised (in dollars per share) | $ / shares	13.46
Stock options canceled (in dollars per share) | $ / shares	16.20
Ending Balance (in dollars per share) | $ / shares	32.20
Vested and expected to vest, Weighted-Average Exercise Price (in dollars per share) | $ / shares	32.20
Exercisable, Weighted-Average Exercise Price (in dollars per share) | $ / shares	$ 32.16
Beginning balance, Aggregate Intrinsic Value | $	$ 90
Ending balance, Aggregate Intrinsic Value | $	16
Vested and expected to vest, Aggregate Intrinsic Value | $	16
Exercisable, Aggregate Intrinsic Value | $	$ 16

Unearned Revenue and Performa_2

Unearned Revenue and Performance Obligations - Narrative (Details) - USD ($) $ in Billions	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Revenue from Contract with Customer [Abstract]
Subscription revenue recognized that was included in total unearned revenue balance at beginning of period	$ 1.2	$ 1	$ 2.7	$ 2.2

Unearned Revenue and Performa_3

Unearned Revenue and Performance Obligations - Transaction Price Allocated to the Remaining Performance Obligations (Details) - Subscription services $ in Billions	Oct. 31, 2022 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue is expected to be recognized from remaining performance obligations for subscription contracts	$ 14.1
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue is expected to be recognized from remaining performance obligations for subscription contracts	$ 8.6
Recognition period (in months)	24 months

Other Income (Expense), Net (De

Other Income (Expense), Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Other Income and Expenses [Abstract]
Interest income	$ 31,252	$ 1,195	$ 50,473	$ 4,531
Interest expense	(29,626)	(4,160)	(73,804)	(12,527)
Other	2,537	24,522	(25,458)	123,487
Total other income (expense), net	$ 4,163	$ 21,557	$ (48,789)	$ 115,491

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Income Tax Disclosure [Abstract]
Provision for (benefit from) income taxes	$ 52,563	$ 2,090	$ 59,021	$ (2,623)

Net Income (Loss) Per Share - S

Net Income (Loss) Per Share - Summary of Calculation of Basic and Diluted Net Income (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Numerator:
Net income (loss)	$ (74,721)	$ 43,412	$ (241,052)	$ 102,626
Denominator:
Weighted-average shares outstanding, basic (in shares)	255,753	248,468	253,975	246,348
Weighted-average shares outstanding, diluted (in shares)	255,753	254,760	253,975	253,917
Net loss per share, basic (in dollars per share)	$ (0.29)	$ 0.17	$ (0.95)	$ 0.42
Net loss per share, diluted (in dollars per share)	$ (0.29)	$ 0.17	$ (0.95)	$ 0.40
Class A
Numerator:
Net income (loss)	$ (58,648)	$ 33,417	$ (188,757)	$ 78,546
Reallocation of net income as a result of conversion of Class B to Class A common stock	0	9,995	0	24,080
Reallocation of net income to Class B common stock	0	0	0	0
Net income (loss) for diluted calculation	$ (58,648)	$ 43,412	$ (188,757)	$ 102,626
Denominator:
Weighted-average shares outstanding, basic (in shares)	200,740	191,259	198,876	188,546
Conversion of Class B to Class A common stock (in shares)	0	57,209	0	57,802
Dilutive effect of share-based awards (in shares)	0	4,933	0	6,456
Dilutive effect of warrants related to the issuance of convertible senior notes (in shares)	0	1,359	0	1,113
Weighted-average shares outstanding, diluted (in shares)	200,740	254,760	198,876	253,917
Net loss per share, basic (in dollars per share)	$ (0.29)	$ 0.17	$ (0.95)	$ 0.42
Net loss per share, diluted (in dollars per share)	$ (0.29)	$ 0.17	$ (0.95)	$ 0.40
Class B
Numerator:
Net income (loss)	$ (16,073)	$ 9,995	$ (52,295)	$ 24,080
Reallocation of net income as a result of conversion of Class B to Class A common stock	0	0	0	0
Reallocation of net income to Class B common stock	0	(247)	0	(718)
Net income (loss) for diluted calculation	$ (16,073)	$ 9,748	$ (52,295)	$ 23,362
Denominator:
Weighted-average shares outstanding, basic (in shares)	55,013	57,209	55,099	57,802
Conversion of Class B to Class A common stock (in shares)	0	0	0	0
Dilutive effect of share-based awards (in shares)	0	0	0	0
Dilutive effect of warrants related to the issuance of convertible senior notes (in shares)	0	0	0	0
Weighted-average shares outstanding, diluted (in shares)	55,013	57,209	55,099	57,802
Net loss per share, basic (in dollars per share)	$ (0.29)	$ 0.17	$ (0.95)	$ 0.42
Net loss per share, diluted (in dollars per share)	$ (0.29)	$ 0.17	$ (0.95)	$ 0.40

Net Income (Loss) Per Share -_2

Net Income (Loss) Per Share - Summary of Diluted Net Income (Loss) Per Common Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive securities (in shares)	29,105	7,968	30,199	9,618
Shares related to outstanding share-based awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive securities (in shares)	16,105	151	15,453	1,801
Shares related to the convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive securities (in shares)	5,182	7,817	6,928	7,817
Shares subject to warrants related to the issuance of convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive securities (in shares)	7,818	0	7,818	0

Geographic Information - Summar

Geographic Information - Summary of Revenues by Geographic Area (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022 USD ($) market	Oct. 31, 2021 USD ($)	Oct. 31, 2022 USD ($) market	Oct. 31, 2021 USD ($)
Disaggregation of Revenue [Line Items]
Number of primary geographical markets | market	2		2
Total revenues	$ 1,599,103	$ 1,327,263	$ 4,569,558	$ 3,762,657
United States
Disaggregation of Revenue [Line Items]
Total revenues	1,204,842	991,747	3,432,249	2,817,749
Other countries
Disaggregation of Revenue [Line Items]
Total revenues	$ 394,261	$ 335,516	$ 1,137,309	$ 944,908

Geographic Information - Long-L

Geographic Information - Long-Lived Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Long-Lived Assets [Line Items]
Total long-lived assets	$ 1,487,237	$ 1,370,883
United States
Long-Lived Assets [Line Items]
Total long-lived assets	1,243,176	1,174,371
Ireland
Long-Lived Assets [Line Items]
Total long-lived assets	158,975	117,049
Other countries
Long-Lived Assets [Line Items]
Total long-lived assets	$ 85,086	$ 79,463

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event - Forecast - USD ($) $ in Millions	1 Months Ended	3 Months Ended
	Nov. 30, 2022	Jan. 31, 2023
Restricted Stock Units
Subsequent Event [Line Items]
Accelerated share-based compensation expense		$ 30
Class A
Subsequent Event [Line Items]
Authorized repurchase amount	$ 500
Term of contract (in months)	18 months